1
00:00:20,880 --> 00:00:23,639
Speaker 1: Hello America, Happy Fridday. Welcome to the latest edition of

2
00:00:23,840 --> 00:00:26,480
Speaker 1: Justin News, No Noise. I'm your host, John Solomon, alongside

3
00:00:26,520 --> 00:00:29,400
Speaker 1: the amazing Amanda d We're gonna do something little different tonight.

4
00:00:29,400 --> 00:00:31,560
Speaker 1: We're gonna let you worry about the breaking news headlines.

5
00:00:32,080 --> 00:00:33,559
Speaker 1: Steve just took care of you for now, you're going

6
00:00:33,600 --> 00:00:35,600
Speaker 1: to get more from Granted a little bit, Justin News

7
00:00:35,600 --> 00:00:37,239
Speaker 1: has got you covered all the way through. We're going

8
00:00:37,320 --> 00:00:39,240
Speaker 1: to go back and take a second or third deep

9
00:00:39,280 --> 00:00:41,559
Speaker 1: dive into I think one of the most important subjects

10
00:00:41,720 --> 00:00:45,760
Speaker 1: facing our country, the critical condition of our pharmaceutical supply chain.

11
00:00:46,120 --> 00:00:48,520
Speaker 1: It has been left in tatters by the Biden administration.

12
00:00:48,600 --> 00:00:51,200
Speaker 1: Donald Trump jumping in right after we did our first

13
00:00:51,200 --> 00:00:55,440
Speaker 1: special on this, Amanda, Donald Trump's folks started announcing executive orders,

14
00:00:55,720 --> 00:01:00,000
Speaker 1: major innovations. Now we're putting the supplies into a strategy

15
00:01:00,200 --> 00:01:02,520
Speaker 1: reserve like we were supposed to legally but weren't under

16
00:01:02,600 --> 00:01:06,200
Speaker 1: Joe Biden. And we're beginning a manufacturing renaissance. But in

17
00:01:06,240 --> 00:01:08,880
Speaker 1: between those two extraordinary solutions, there's a window of time

18
00:01:08,880 --> 00:01:12,640
Speaker 1: where America has to produce generic drugs without large factories

19
00:01:12,640 --> 00:01:15,160
Speaker 1: capable of doing that. Tonight, We're going to let you

20
00:01:15,280 --> 00:01:17,360
Speaker 1: peer into the future a little bit with an all

21
00:01:17,360 --> 00:01:19,399
Speaker 1: star cast of guest. Tonight, we're going to show you

22
00:01:19,680 --> 00:01:22,640
Speaker 1: what's going to be possible soon a room about the

23
00:01:22,680 --> 00:01:24,160
Speaker 1: size of the studio. What we're in right now in

24
00:01:24,600 --> 00:01:26,639
Speaker 1: Man and nine can turn out a whole year's supply

25
00:01:26,680 --> 00:01:30,480
Speaker 1: of a generic antabotic because of these new innovative technologies.

26
00:01:30,640 --> 00:01:32,280
Speaker 1: We're going to show you what that means and how

27
00:01:32,319 --> 00:01:34,840
Speaker 1: it could radically change the next two or three years

28
00:01:34,840 --> 00:01:37,800
Speaker 1: of medicine in America. We have the perfect guest to

29
00:01:37,880 --> 00:01:39,800
Speaker 1: kick us off on that venture today, Amanda. I can't

30
00:01:39,840 --> 00:01:41,840
Speaker 1: wait to get started all right, Joining us now the

31
00:01:41,880 --> 00:01:44,720
Speaker 1: point man who's made all of this extraordinary progress happen

32
00:01:44,760 --> 00:01:47,920
Speaker 1: inside the Trump administration. He's the Principal Deputy Assistant Secretary

33
00:01:47,920 --> 00:01:51,280
Speaker 1: for Preparedness and Responses at the Health and Human Services Department,

34
00:01:51,760 --> 00:01:52,360
Speaker 1: John Knox.

35
00:01:52,400 --> 00:01:55,680
Speaker 2: John, great to have you on the show, Sarah.

36
00:01:54,680 --> 00:01:56,440
Speaker 3: Thank you, Thank you for having me on again.

37
00:01:57,360 --> 00:01:59,520
Speaker 1: It's kind of funny because over the last four years

38
00:01:59,600 --> 00:02:03,280
Speaker 1: we watched the Biden administration accomplished nothing in this clear

39
00:02:03,320 --> 00:02:06,000
Speaker 1: problem that we've had a critical condition in our pharmaceutical

40
00:02:06,000 --> 00:02:08,760
Speaker 1: supply lines. You guys are in just a few months,

41
00:02:08,840 --> 00:02:12,600
Speaker 1: and there has been such enormous progress. The executive order

42
00:02:12,600 --> 00:02:16,440
Speaker 1: obviously a signature moment, but almost daily your department is

43
00:02:16,480 --> 00:02:18,040
Speaker 1: moving this down the road so that we get to

44
00:02:18,080 --> 00:02:21,800
Speaker 1: a full manufacturing capability, a full supply chain. Bring us

45
00:02:21,840 --> 00:02:23,520
Speaker 1: up to speed. And what's just happened since the last

46
00:02:23,560 --> 00:02:24,160
Speaker 1: time we had.

47
00:02:24,000 --> 00:02:27,000
Speaker 4: The on the show, Well, as you know, the President

48
00:02:27,360 --> 00:02:30,440
Speaker 4: has definitely made it clear that he wants to bring

49
00:02:30,600 --> 00:02:35,240
Speaker 4: manufacturing back to the United States and that includes critical

50
00:02:35,280 --> 00:02:39,000
Speaker 4: medications for the American people. As we talked about last time,

51
00:02:39,360 --> 00:02:42,680
Speaker 4: one of the issues is that over seventy percent of

52
00:02:42,720 --> 00:02:46,960
Speaker 4: the API's active pharmaceutical ingredients and the key starting materials

53
00:02:47,280 --> 00:02:52,480
Speaker 4: that are used for manufacturing medications are produced in China

54
00:02:52,520 --> 00:02:57,119
Speaker 4: and India. And the other critical issue is that over

55
00:02:57,240 --> 00:02:59,640
Speaker 4: ninety percent of all of our antibiotics are produced there

56
00:02:59,639 --> 00:03:04,280
Speaker 4: as well. And so they've looked at that, both Secretary

57
00:03:04,360 --> 00:03:08,760
Speaker 4: Kennedy and President Trump, and they have you know, tasked

58
00:03:08,800 --> 00:03:14,000
Speaker 4: us with bringing that back onshore and strengthening our manufacturing

59
00:03:14,520 --> 00:03:18,600
Speaker 4: capacities as it falls under a national security issue.

60
00:03:18,760 --> 00:03:23,560
Speaker 5: Absolutely, sir, look no further than yesterday and Secretary Kennedy's

61
00:03:23,880 --> 00:03:26,400
Speaker 5: hearing up on Capitol Hills to know that Democrats are

62
00:03:26,440 --> 00:03:28,400
Speaker 5: standing against a lot of the good work that you

63
00:03:28,480 --> 00:03:31,120
Speaker 5: guys are doing at HHS. But this might be different this.

64
00:03:31,440 --> 00:03:34,000
Speaker 5: You know, Republicans get sick, Democrats do too. Does it

65
00:03:34,000 --> 00:03:36,080
Speaker 5: feel like this is bipartisan.

66
00:03:37,520 --> 00:03:42,640
Speaker 4: You know, I mean we have it's for our organization

67
00:03:42,800 --> 00:03:45,800
Speaker 4: and what we're doing. We have, you know, support from

68
00:03:45,840 --> 00:03:48,400
Speaker 4: both the House and the Senate regarding you know, fiscal

69
00:03:48,480 --> 00:03:52,120
Speaker 4: year twenty six, they did indicate funding to continue to

70
00:03:52,200 --> 00:03:56,160
Speaker 4: support these efforts, though modest, but.

71
00:03:56,160 --> 00:03:59,560
Speaker 3: It's still going to allow us to help push this forward.

72
00:04:00,800 --> 00:04:05,600
Speaker 4: So they understand that it's important that we as Americans

73
00:04:05,720 --> 00:04:09,720
Speaker 4: be strong in the field of medicine, and so they've

74
00:04:09,760 --> 00:04:12,400
Speaker 4: tasked us, like I said, to really come up with

75
00:04:12,520 --> 00:04:16,320
Speaker 4: creative solutions to be able to solve those problems and

76
00:04:16,400 --> 00:04:17,880
Speaker 4: start on shoring medications.

77
00:04:18,400 --> 00:04:20,600
Speaker 2: Yeah, so important, all right.

78
00:04:20,640 --> 00:04:23,159
Speaker 1: So we've done a lot to understand the bookends to

79
00:04:23,240 --> 00:04:25,360
Speaker 1: this great strategy that you put in the case. We've

80
00:04:25,360 --> 00:04:27,520
Speaker 1: got the big, big beautiful bill that creates all these

81
00:04:27,520 --> 00:04:30,520
Speaker 1: incentives that we start building the big beautiful factories that

82
00:04:30,600 --> 00:04:34,080
Speaker 1: will make the making particular generic drugs more common in

83
00:04:34,080 --> 00:04:37,120
Speaker 1: American more regular and take away the vulnerability in the

84
00:04:37,160 --> 00:04:40,040
Speaker 1: short term, you filled the strategic stockpile back up that's

85
00:04:40,040 --> 00:04:42,960
Speaker 1: starting to happen. That is a big moment in between

86
00:04:43,080 --> 00:04:45,040
Speaker 1: we're starting today. We've been just doing some reporting or

87
00:04:45,080 --> 00:04:47,640
Speaker 1: learning a lot. There seems to be some innovative solutions

88
00:04:47,640 --> 00:04:51,480
Speaker 1: that your administration is looking at where you can produce

89
00:04:51,520 --> 00:04:53,960
Speaker 1: a certain amount of generic drugs pretty quickly in like

90
00:04:53,960 --> 00:04:56,560
Speaker 1: a one room factory that's sort of almost like virtual

91
00:04:56,600 --> 00:05:00,560
Speaker 1: printers of very clean, safe drugs. US a little bit

92
00:05:00,600 --> 00:05:02,760
Speaker 1: about some of the innovative ideas that are being thought

93
00:05:02,800 --> 00:05:05,200
Speaker 1: about to fill the gap before those big factories that

94
00:05:05,200 --> 00:05:06,480
Speaker 1: got their assembly lines running.

95
00:05:07,400 --> 00:05:11,200
Speaker 4: Well, I think that's really crucial in when we look

96
00:05:11,240 --> 00:05:14,920
Speaker 4: at onshoring medications. Right, we here in the United States

97
00:05:14,920 --> 00:05:17,800
Speaker 4: have a completely different labor force than what they do

98
00:05:17,839 --> 00:05:20,520
Speaker 4: in China and India. Right, we don't have slave labor

99
00:05:20,560 --> 00:05:27,000
Speaker 4: here and competing at those levels with huge bulk factories, we.

100
00:05:27,000 --> 00:05:29,359
Speaker 3: Don't have the capacity or the ability to do that.

101
00:05:29,560 --> 00:05:32,760
Speaker 4: So we have to look at new and innovative ways,

102
00:05:32,800 --> 00:05:37,960
Speaker 4: like you mentioned on how to strategically come up with ways,

103
00:05:38,360 --> 00:05:44,560
Speaker 4: you know, to make things simpler and faster and so

104
00:05:44,680 --> 00:05:49,000
Speaker 4: by you know, reaching out to our private partner industry,

105
00:05:49,440 --> 00:05:52,200
Speaker 4: you know, having public private partnerships.

106
00:05:52,000 --> 00:05:53,080
Speaker 3: We have the ability.

107
00:05:53,120 --> 00:05:55,960
Speaker 4: There is a lot of ingenuity here in America. There

108
00:05:55,960 --> 00:05:58,560
Speaker 4: always has been, it's just been stifled for years. And

109
00:05:58,600 --> 00:06:01,960
Speaker 4: so really our task right now is looking at what

110
00:06:02,000 --> 00:06:06,280
Speaker 4: those innovative technologies are and how we can apply them

111
00:06:06,320 --> 00:06:08,720
Speaker 4: to Like you said, I mean, we we can do

112
00:06:09,839 --> 00:06:13,680
Speaker 4: three D printing of medications in pill form we have

113
00:06:14,360 --> 00:06:17,880
Speaker 4: we're working on projects that we don't.

114
00:06:17,680 --> 00:06:19,479
Speaker 3: Have to have the key starting materials.

115
00:06:19,520 --> 00:06:23,760
Speaker 4: It completely bypasses that to make the active pharmaceutical ingredient.

116
00:06:24,760 --> 00:06:28,760
Speaker 4: So we're looking at these ways how we can jump

117
00:06:28,800 --> 00:06:34,240
Speaker 4: ahead of the curve using technology, sound technology to be

118
00:06:34,320 --> 00:06:37,760
Speaker 4: able to bring that onshoing back here to compete with

119
00:06:37,800 --> 00:06:41,200
Speaker 4: those companies you know in China and India.

120
00:06:41,680 --> 00:06:43,240
Speaker 2: This is pretty big stuff.

121
00:06:43,000 --> 00:06:44,320
Speaker 6: Absolutely, sir.

122
00:06:44,360 --> 00:06:47,039
Speaker 5: When it comes to the ksms and the APIs, the

123
00:06:47,120 --> 00:06:50,159
Speaker 5: things that you know, I think that is very conceivable

124
00:06:50,200 --> 00:06:52,640
Speaker 5: that we can onshore those very very soon. How many

125
00:06:52,680 --> 00:06:55,480
Speaker 5: different drugs can you make from those? Are we talking

126
00:06:55,560 --> 00:06:59,200
Speaker 5: a few dozens hundreds? How many can we make from those?

127
00:07:00,160 --> 00:07:03,960
Speaker 4: So the you know, you have the key starting materials

128
00:07:03,960 --> 00:07:07,320
Speaker 4: and those are all the pieces that go into the

129
00:07:07,360 --> 00:07:12,800
Speaker 4: API that make the active pharmaceutical ingredient. Each medication has

130
00:07:13,000 --> 00:07:17,680
Speaker 4: usually a specific API that it uses, so there are

131
00:07:17,760 --> 00:07:22,360
Speaker 4: some that use you know, multiples, but primarily it's you know,

132
00:07:22,400 --> 00:07:25,840
Speaker 4: whether it's atropine or latycaine or whatever the drug is

133
00:07:25,840 --> 00:07:30,160
Speaker 4: that you're looking to manufacture, you have that API for that,

134
00:07:30,240 --> 00:07:32,720
Speaker 4: So it's usually on a one to one for basis.

135
00:07:33,400 --> 00:07:37,080
Speaker 4: So we do have companies that we're working with that

136
00:07:37,200 --> 00:07:41,320
Speaker 4: are actually now producing APIs here in the United States

137
00:07:41,400 --> 00:07:46,160
Speaker 4: and that's super exciting. And we have some fantastic technology

138
00:07:46,960 --> 00:07:51,040
Speaker 4: and other companies that we're working with that are in

139
00:07:51,080 --> 00:07:54,760
Speaker 4: the process of bringing this to market to where you know,

140
00:07:54,840 --> 00:07:58,480
Speaker 4: it used to take us months to create an API,

141
00:07:58,720 --> 00:08:01,800
Speaker 4: and we can we will be able to do we can,

142
00:08:02,200 --> 00:08:05,400
Speaker 4: but moving it forward through the regulatory process, we will

143
00:08:05,400 --> 00:08:08,200
Speaker 4: be able to do that in hours. So you know,

144
00:08:08,280 --> 00:08:12,080
Speaker 4: the technology is there and American innovation is striving to

145
00:08:12,800 --> 00:08:15,760
Speaker 4: you know, take back the market that we've lost over

146
00:08:15,800 --> 00:08:17,040
Speaker 4: the past fifty years.

147
00:08:17,480 --> 00:08:20,480
Speaker 1: So amazing when you uh, some of the people I've

148
00:08:20,480 --> 00:08:22,200
Speaker 1: talked to over the last few days compared this to

149
00:08:22,240 --> 00:08:24,200
Speaker 1: putting man on the moon, that what's going on is

150
00:08:24,280 --> 00:08:28,400
Speaker 1: so innovative, it's so advanced technology. It's so groundbreaking after

151
00:08:28,520 --> 00:08:31,240
Speaker 1: fifty years or forty years of allies and letting this

152
00:08:31,360 --> 00:08:34,760
Speaker 1: incredible industry gravitate to an enemy or to a country

153
00:08:34,800 --> 00:08:38,360
Speaker 1: that has some equality control problems with it's a drug

154
00:08:38,360 --> 00:08:43,480
Speaker 1: supply chain. When this administration is done, how significant is

155
00:08:43,520 --> 00:08:46,440
Speaker 1: this to the future of America Achieving this sort of

156
00:08:46,880 --> 00:08:49,880
Speaker 1: in house pharmaceutical capability Again.

157
00:08:50,679 --> 00:08:51,520
Speaker 3: It's huge, you know.

158
00:08:51,600 --> 00:08:54,520
Speaker 4: I mean if you look at it from different standpoints,

159
00:08:55,080 --> 00:08:58,920
Speaker 4: We've offshored everything in manufacturing over the past fifty years,

160
00:08:59,160 --> 00:09:02,360
Speaker 4: and we've become a cert service industry. Right, a lot

161
00:09:02,360 --> 00:09:05,079
Speaker 4: of this technology that we'll be able to move forward,

162
00:09:05,400 --> 00:09:09,559
Speaker 4: you know, if you look at it, I mean trade schools.

163
00:09:09,559 --> 00:09:12,240
Speaker 4: The presidents talked about trade schools and things like that. Right,

164
00:09:12,960 --> 00:09:16,079
Speaker 4: Using those types of things, we can train people up

165
00:09:16,120 --> 00:09:20,640
Speaker 4: to be able to work in these facilities, to be

166
00:09:20,679 --> 00:09:23,640
Speaker 4: able to bring jobs back to America, right. I mean,

167
00:09:24,760 --> 00:09:28,640
Speaker 4: we're suffering from a.

168
00:09:28,600 --> 00:09:29,440
Speaker 3: Lot of things, you know.

169
00:09:29,559 --> 00:09:31,800
Speaker 4: I don't want to go into everything, but the point

170
00:09:31,800 --> 00:09:34,040
Speaker 4: being is that at the end of this, I mean,

171
00:09:34,080 --> 00:09:36,160
Speaker 4: this will be significant. Not only will we have on

172
00:09:36,320 --> 00:09:39,040
Speaker 4: short you know, medications and be able to do them

173
00:09:39,080 --> 00:09:43,200
Speaker 4: cheaper and faster. You mentioned the big beautiful bill, you know.

174
00:09:43,280 --> 00:09:47,880
Speaker 4: I mean that's provided significant funding for DPA, which is

175
00:09:47,920 --> 00:09:54,160
Speaker 4: the Defense Production Act, and so using those authorities, you know,

176
00:09:54,200 --> 00:09:56,600
Speaker 4: with Asper and our partners, we're working on how to

177
00:09:56,800 --> 00:10:02,240
Speaker 4: use those authorities to create success, you know, regulatory relief

178
00:10:02,360 --> 00:10:06,360
Speaker 4: through the President's one of his executive orders on promoting

179
00:10:06,360 --> 00:10:10,240
Speaker 4: domestic production for critical medicines. All of these levers and

180
00:10:10,320 --> 00:10:12,960
Speaker 4: things that are being pulled right now are being done

181
00:10:13,160 --> 00:10:17,880
Speaker 4: so that we can help the manufacturers start on shoring this.

182
00:10:18,080 --> 00:10:21,400
Speaker 4: Whether you know he's using tariffs, tax incentives, I mean,

183
00:10:21,440 --> 00:10:24,600
Speaker 4: there's a lot of different things that he's working on to.

184
00:10:25,080 --> 00:10:27,319
Speaker 3: To move that through. And with the sec.

185
00:10:28,520 --> 00:10:31,360
Speaker 4: Secretary Kennedy, I mean they're on the same page. They

186
00:10:31,480 --> 00:10:34,760
Speaker 4: want to make Americans healthier. We do know that we

187
00:10:34,920 --> 00:10:39,120
Speaker 4: have a sick population in our country and you know,

188
00:10:39,240 --> 00:10:43,920
Speaker 4: having specific critical medications that help in that not only

189
00:10:44,000 --> 00:10:48,400
Speaker 4: his vision of getting people healthier, but there are always

190
00:10:48,400 --> 00:10:50,720
Speaker 4: going to be a need for critical medications, and so

191
00:10:51,280 --> 00:10:54,240
Speaker 4: you know, moving that forward I think is really crucial

192
00:10:54,920 --> 00:10:57,199
Speaker 4: at this point. And at the end, I think we're

193
00:10:57,240 --> 00:10:58,920
Speaker 4: going to be sitting in a really good place.

194
00:11:00,000 --> 00:11:01,840
Speaker 1: I think that that's true and the reporting that we've

195
00:11:01,840 --> 00:11:03,640
Speaker 1: done on this is just amazing to us. It really

196
00:11:03,720 --> 00:11:06,840
Speaker 1: is an incredible process, and you are right in the

197
00:11:06,880 --> 00:11:08,839
Speaker 1: middle driving this. It's a great honor. I know how

198
00:11:08,840 --> 00:11:10,320
Speaker 1: busy you are, but a great honor to kick off

199
00:11:10,360 --> 00:11:12,520
Speaker 1: our show tonight with your time. And thank you so

200
00:11:12,640 --> 00:11:14,160
Speaker 1: much for making yourself available.

201
00:11:14,920 --> 00:11:15,719
Speaker 3: I appreciate it.

202
00:11:15,720 --> 00:11:18,640
Speaker 4: It's an exciting time to be, you know, an American

203
00:11:18,720 --> 00:11:22,560
Speaker 4: and looking at what the administration wants right now is

204
00:11:22,640 --> 00:11:26,120
Speaker 4: really to boost the economy and bring manufacturing back, and

205
00:11:26,160 --> 00:11:28,240
Speaker 4: so we're going to do everything that we can to

206
00:11:28,320 --> 00:11:29,000
Speaker 4: make that happen.

207
00:11:29,480 --> 00:11:32,480
Speaker 1: Making that access access to those generic drugs will be

208
00:11:32,559 --> 00:11:35,199
Speaker 1: so important. What an amazing milestone to be aiming for.

209
00:11:35,480 --> 00:11:38,240
Speaker 1: Thanks again for your time, Sarah, Thank you. All right, folks,

210
00:11:38,240 --> 00:11:39,920
Speaker 1: a quick commercial break ahead. Let me come back, and

211
00:11:40,000 --> 00:11:43,920
Speaker 1: we have a congress woman, a doctor Marinette Miller Milks,

212
00:11:43,960 --> 00:11:45,760
Speaker 1: so'll be here at meeks, I'm sorry, we'll be here

213
00:11:45,760 --> 00:11:48,120
Speaker 1: to discuss more about what Congress is doing on this

214
00:11:48,200 --> 00:11:48,880
Speaker 1: important issue.

215
00:11:48,920 --> 00:11:54,520
Speaker 2: That's right right, all right, after this, Hey, folks, let's

216
00:11:54,559 --> 00:11:56,080
Speaker 2: be honest our body. Lets us know right.

217
00:11:56,000 --> 00:11:58,040
Speaker 1: We're not getting any younger. And if you want to

218
00:11:58,040 --> 00:12:00,640
Speaker 1: look and fill your best you need to check. Aren't

219
00:12:00,679 --> 00:12:03,680
Speaker 1: good friends. At Pure health Research, they have forty five

220
00:12:03,720 --> 00:12:07,079
Speaker 1: premium health supplements designed to help with every health goal.

221
00:12:07,120 --> 00:12:10,520
Speaker 1: Whether it's boosting your energy, trimming belly fat, supporting healthy

222
00:12:10,559 --> 00:12:14,559
Speaker 1: blood sugar, pumping your testosterone up, or even reducing swelling

223
00:12:14,640 --> 00:12:18,280
Speaker 1: in your legs, Pure Health Research Supplement Store has you covered.

224
00:12:18,440 --> 00:12:21,680
Speaker 1: Each formula is crafted with natural, non GMO ingredients, backed

225
00:12:21,720 --> 00:12:24,520
Speaker 1: by clinical research, and manufactured right here at the good

226
00:12:24,559 --> 00:12:27,760
Speaker 1: old USA. And here's the best part. Pure Health Research

227
00:12:27,920 --> 00:12:31,280
Speaker 1: is offering you an exclusive thirty five percent discount. You're right,

228
00:12:31,320 --> 00:12:33,800
Speaker 1: thirty five percent off. Just go to Pure health research

229
00:12:33,920 --> 00:12:37,080
Speaker 1: dot com use the coupon code just News to check out.

230
00:12:37,280 --> 00:12:40,199
Speaker 1: With their three hundred and sixty five day money back guarantee.

231
00:12:40,200 --> 00:12:43,240
Speaker 1: There's zero risk in trying something new, so why wait.

232
00:12:43,280 --> 00:12:47,160
Speaker 1: Head over to purehealthresearch dot com right now explore their

233
00:12:47,160 --> 00:12:50,600
Speaker 1: forty five amazing supplements and save thirty five percent before

234
00:12:50,640 --> 00:12:54,000
Speaker 1: this deal ends with the qupon code just News. Don't

235
00:12:54,040 --> 00:13:04,960
Speaker 1: miss this chance to fill your best.

236
00:13:08,120 --> 00:13:11,360
Speaker 5: Welcome back everybody, Because we had such positive reception the

237
00:13:11,400 --> 00:13:13,920
Speaker 5: first time around, we are taking another look at America's

238
00:13:13,960 --> 00:13:17,440
Speaker 5: pharmaceutical industry tonight because President Trump has taken steps to

239
00:13:17,559 --> 00:13:20,560
Speaker 5: get some crucial pharmaceuticals made here in the United States

240
00:13:20,559 --> 00:13:23,480
Speaker 5: as opposed to countries like China and India. So joining

241
00:13:23,520 --> 00:13:25,960
Speaker 5: us now to talk about those steps and what Congress

242
00:13:26,040 --> 00:13:28,320
Speaker 5: might be able to do as well, is a doctor

243
00:13:28,480 --> 00:13:31,800
Speaker 5: an Iowa Congresswoman Marionette Miller meets Congresswoman. Thank you so

244
00:13:31,880 --> 00:13:32,679
Speaker 5: much for being here.

245
00:13:33,200 --> 00:13:34,440
Speaker 6: It's great to be with you both.

246
00:13:36,000 --> 00:13:38,600
Speaker 5: You know, President Trump, along with Congress, you guys have

247
00:13:38,640 --> 00:13:42,559
Speaker 5: supported some really really innovative measures to bring the pharmaceutical

248
00:13:42,559 --> 00:13:45,720
Speaker 5: industry back to the United States. It seems like maybe

249
00:13:45,760 --> 00:13:49,560
Speaker 5: one of the most influential is the regulatory relief that

250
00:13:49,640 --> 00:13:52,160
Speaker 5: could be offered as an incentive to bring that industry

251
00:13:52,200 --> 00:13:53,760
Speaker 5: back home. But what are going to be some of

252
00:13:53,800 --> 00:13:56,480
Speaker 5: the next steps that are important in making sure that

253
00:13:56,600 --> 00:13:59,880
Speaker 5: this solution is finally brought home, sewed up with a

254
00:14:00,040 --> 00:14:02,040
Speaker 5: bow on it, so that the American people can feel

255
00:14:02,080 --> 00:14:03,319
Speaker 5: secure about the drugs that they.

256
00:14:03,320 --> 00:14:04,240
Speaker 6: Might need in a crisis.

257
00:14:05,400 --> 00:14:09,520
Speaker 7: What's interesting about this is that certainly the pandemic highlighted

258
00:14:09,880 --> 00:14:12,640
Speaker 7: the need to have pharmaceutical supply chains here in the

259
00:14:12,760 --> 00:14:15,920
Speaker 7: United States. We talked a lot about this. We talked

260
00:14:15,920 --> 00:14:21,320
Speaker 7: about the strategic national reserve and how we one shore, how.

261
00:14:21,120 --> 00:14:22,320
Speaker 6: We have things available.

262
00:14:22,640 --> 00:14:26,080
Speaker 7: As you know, we have drug shortages for different drugs

263
00:14:26,400 --> 00:14:30,520
Speaker 7: intermittently throughout the years. We know that there was difficulties

264
00:14:30,560 --> 00:14:34,960
Speaker 7: getting medications or mail or pet food from China if

265
00:14:34,960 --> 00:14:38,880
Speaker 7: people will remember a decade ago, those issues that had arisen.

266
00:14:39,440 --> 00:14:42,160
Speaker 7: And so even though we know this is a problem,

267
00:14:42,440 --> 00:14:45,520
Speaker 7: and both candidates talked about it in the run up

268
00:14:45,520 --> 00:14:48,080
Speaker 7: to the twenty twenty election, we had four years where

269
00:14:48,120 --> 00:14:52,040
Speaker 7: absolutely nothing was done. So this president is finally doing

270
00:14:52,080 --> 00:14:56,840
Speaker 7: something about it. And so I think the platform that

271
00:14:56,880 --> 00:15:02,880
Speaker 7: they have put forward on Advanced Pharmaceutical Ingredients or APIs

272
00:15:03,000 --> 00:15:09,440
Speaker 7: also key Pharmaceutical Ingredients KPIs. We've done some things in Congress.

273
00:15:09,440 --> 00:15:11,360
Speaker 7: We just had a hearing on this and the Energy

274
00:15:11,400 --> 00:15:14,240
Speaker 7: and Commerce Committee on the Health subcommittee of which I'm

275
00:15:14,280 --> 00:15:17,840
Speaker 7: a member, so we've had a hearing on that we

276
00:15:17,920 --> 00:15:21,560
Speaker 7: will be doing more, will be addressing drug shortages, and

277
00:15:21,640 --> 00:15:25,360
Speaker 7: so in alignment with what the President is doing, recognizing

278
00:15:25,400 --> 00:15:30,240
Speaker 7: the need for manufacturing, generic manufacturing, having more competition and

279
00:15:30,280 --> 00:15:33,480
Speaker 7: more available. And let me also say that in addition

280
00:15:33,520 --> 00:15:37,800
Speaker 7: to what the President has just released, what Congress did

281
00:15:37,880 --> 00:15:41,280
Speaker 7: and the President signed was the one big beautiful bill.

282
00:15:41,400 --> 00:15:45,000
Speaker 7: So when it comes to manufacturing and support for manufacturing,

283
00:15:45,400 --> 00:15:49,360
Speaker 7: all of those provisions, the tax provisions, the capital expensing,

284
00:15:49,440 --> 00:15:55,400
Speaker 7: the keeping the corporate interest rate down, the bonus depreciation,

285
00:15:56,400 --> 00:15:59,880
Speaker 7: immediate expensing one hundred percent for research and development or RM,

286
00:16:00,640 --> 00:16:04,080
Speaker 7: all of those are things that help us to build

287
00:16:04,160 --> 00:16:08,480
Speaker 7: manufacturing here in Iowa and in the United States.

288
00:16:08,520 --> 00:16:10,960
Speaker 6: But more importantly it helps.

289
00:16:10,680 --> 00:16:13,480
Speaker 7: Any kind of company, and pharmaceutical companies are one that's

290
00:16:13,520 --> 00:16:16,240
Speaker 7: going to benefit. The other thing is we have to

291
00:16:16,280 --> 00:16:18,920
Speaker 7: make sure that the FTC does its job. And when

292
00:16:18,920 --> 00:16:23,640
Speaker 7: there's too much vertical integration so it ends competition, then

293
00:16:23,840 --> 00:16:26,440
Speaker 7: that's where the FTC needs to step in. When you

294
00:16:26,520 --> 00:16:30,280
Speaker 7: have consolidation in a marketplace so you don't have competition,

295
00:16:30,360 --> 00:16:33,200
Speaker 7: that helps bring down costs. And then thirdly is the

296
00:16:33,240 --> 00:16:36,320
Speaker 7: work that we're doing on pharmacy benefit managers and looking

297
00:16:36,320 --> 00:16:40,040
Speaker 7: at the entire supply chain, looking at this opaque middleman

298
00:16:40,520 --> 00:16:43,480
Speaker 7: and helping to bring supply costs down. But it also

299
00:16:43,520 --> 00:16:50,200
Speaker 7: helps support pharmaceutical industry, including generic pharmaceuticals.

300
00:16:50,240 --> 00:16:53,000
Speaker 1: Pretty impressive what's been accomplished in a few short months

301
00:16:53,000 --> 00:16:54,840
Speaker 1: in Congress from when you've been at the forefront of

302
00:16:54,880 --> 00:16:58,080
Speaker 1: this in Congress, one of the most influential persons there.

303
00:16:58,160 --> 00:17:00,400
Speaker 1: Now we got Jay Botchara the press, and on the

304
00:17:00,440 --> 00:17:01,920
Speaker 1: administration side, it.

305
00:17:01,880 --> 00:17:03,480
Speaker 2: Seems like the bookends are built.

306
00:17:03,480 --> 00:17:06,640
Speaker 1: We've got the supply chain now bringing in the ingredients,

307
00:17:06,640 --> 00:17:09,200
Speaker 1: and we're finally filling our strategic reserve that Joe Biden

308
00:17:09,280 --> 00:17:11,959
Speaker 1: left empty, and we've got the incentives to build these

309
00:17:12,000 --> 00:17:14,960
Speaker 1: big manufacturing facilities that are maybe two to five years out.

310
00:17:15,400 --> 00:17:17,080
Speaker 1: A lot of people are wondering what are some of

311
00:17:17,160 --> 00:17:19,760
Speaker 1: the innovative ideas to fill the gap when you have

312
00:17:19,840 --> 00:17:22,399
Speaker 1: the ingredients but not the manufacturing capability.

313
00:17:22,440 --> 00:17:23,640
Speaker 2: I know there are some new.

314
00:17:23,760 --> 00:17:26,520
Speaker 1: Technologies where basically you can build a factory in a room,

315
00:17:26,560 --> 00:17:28,520
Speaker 1: and you know you don't have mass scale, but you

316
00:17:28,560 --> 00:17:31,760
Speaker 1: can start making some of the drugs in their entirety.

317
00:17:32,040 --> 00:17:33,520
Speaker 1: Can you give us some of the things you've been

318
00:17:33,520 --> 00:17:35,680
Speaker 1: looking at that maybe is a good interim solution until

319
00:17:35,720 --> 00:17:37,400
Speaker 1: we get those big beautiful factories back.

320
00:17:38,320 --> 00:17:39,520
Speaker 6: Well, first, let.

321
00:17:39,359 --> 00:17:42,720
Speaker 7: Me say what you mentioned about the Strategic National Reserve.

322
00:17:42,840 --> 00:17:46,159
Speaker 7: So it's critically important, and so we're looking at when

323
00:17:46,200 --> 00:17:51,040
Speaker 7: we're talking about advanced pharmaceutical ingredients are key pharmaceutical ingredients.

324
00:17:51,240 --> 00:17:55,760
Speaker 7: Those are the building blocks for medications, be they generics,

325
00:17:55,800 --> 00:18:00,520
Speaker 7: be they antibiotics, generic antibiotics, you know, having a reserve

326
00:18:00,680 --> 00:18:03,840
Speaker 7: of those is critically important because that's how you build

327
00:18:03,840 --> 00:18:07,760
Speaker 7: those medications. So first and foremost, I think that portion

328
00:18:07,840 --> 00:18:10,960
Speaker 7: of it looking at the building blocks the supply chain.

329
00:18:11,760 --> 00:18:14,000
Speaker 7: People hadn't really looked at that, and as I said,

330
00:18:14,000 --> 00:18:16,200
Speaker 7: we just had a hearing on this in the Energy

331
00:18:16,240 --> 00:18:19,440
Speaker 7: and Commerce Committee, So I think that's important. The tax

332
00:18:19,480 --> 00:18:24,040
Speaker 7: provisions are important also, but we also have to expand

333
00:18:24,080 --> 00:18:28,159
Speaker 7: that to testing reagents, those ingredients that we know that

334
00:18:28,200 --> 00:18:32,000
Speaker 7: there was a short supply chain, and then looking at

335
00:18:32,000 --> 00:18:34,879
Speaker 7: where we have drug shortages and how we have those components,

336
00:18:35,240 --> 00:18:38,119
Speaker 7: so you can have tax provisions that help with manufacturing.

337
00:18:38,200 --> 00:18:41,960
Speaker 7: To your point, we have some manufacturers already here. Can

338
00:18:42,000 --> 00:18:46,159
Speaker 7: we use compounding pharmacies in the interim for short term shortages.

339
00:18:47,200 --> 00:18:49,640
Speaker 7: That's not a long term solution, but it is a

340
00:18:49,680 --> 00:18:52,840
Speaker 7: solution to use compounding pharmacies already in the United States,

341
00:18:53,200 --> 00:18:56,560
Speaker 7: and we're already doing that with some of the medications

342
00:18:56,560 --> 00:19:01,200
Speaker 7: we have in shortages until we allow larger or manufacturing

343
00:19:01,240 --> 00:19:04,080
Speaker 7: facilities to be stood up. So I think that we've

344
00:19:04,080 --> 00:19:06,720
Speaker 7: got the key building blocks to be able to do this,

345
00:19:07,000 --> 00:19:10,919
Speaker 7: and then we've got some interim provisions that will assist also.

346
00:19:11,600 --> 00:19:13,840
Speaker 7: So I think we're on the right track. We just

347
00:19:13,880 --> 00:19:17,280
Speaker 7: need to recognize the problem, which we've done, and then

348
00:19:17,320 --> 00:19:19,160
Speaker 7: put forced solutions to that problem.

349
00:19:21,000 --> 00:19:24,280
Speaker 5: Absolutely, Congresswoman. As a physician, do you see a delineation

350
00:19:24,720 --> 00:19:27,159
Speaker 5: between what gets prioritized and what doesn't?

351
00:19:27,200 --> 00:19:28,639
Speaker 6: Because you know you've got.

352
00:19:28,480 --> 00:19:31,439
Speaker 5: Issues like I don't know, psoriasis or Russell's leg syndrome.

353
00:19:31,440 --> 00:19:33,440
Speaker 5: While I'm sure those are awful to deal with, it's

354
00:19:33,440 --> 00:19:35,840
Speaker 5: not the same as a chemo drug or even an

355
00:19:35,880 --> 00:19:38,560
Speaker 5: antibiotic where if it's not treated, you can become septic

356
00:19:38,600 --> 00:19:41,680
Speaker 5: and die. Do you see a delineation where we can

357
00:19:41,880 --> 00:19:45,000
Speaker 5: prioritize certain things to come back home and other things

358
00:19:45,040 --> 00:19:46,800
Speaker 5: maybe can come home.

359
00:19:46,640 --> 00:19:47,240
Speaker 6: But just later.

360
00:19:48,800 --> 00:19:52,040
Speaker 7: Absolutely, I think that looking at that, and that's why

361
00:19:52,080 --> 00:19:56,400
Speaker 7: it was important to address both the APIs and the keypis,

362
00:19:56,840 --> 00:20:01,160
Speaker 7: those building blocks for drugs. We know that most generic

363
00:20:01,240 --> 00:20:05,720
Speaker 7: drugs and antibiotics are developed overseas, so bringing that back

364
00:20:05,760 --> 00:20:09,879
Speaker 7: in and addressing those shortages and then also antibiotic resistance,

365
00:20:09,920 --> 00:20:12,160
Speaker 7: So I do think that there is an opportunity for

366
00:20:12,280 --> 00:20:16,240
Speaker 7: a tiered approach, and this is also how we sell drugs,

367
00:20:16,240 --> 00:20:19,280
Speaker 7: how we dispense drugs, So it's a you know, an

368
00:20:19,400 --> 00:20:22,320
Speaker 7: entire supply chain that we have to look at. But yes,

369
00:20:22,400 --> 00:20:25,200
Speaker 7: we should prioritize and we also have to pay enough

370
00:20:25,720 --> 00:20:30,400
Speaker 7: for medications that these generic medications can be made here

371
00:20:30,400 --> 00:20:31,400
Speaker 7: in the United States.

372
00:20:31,840 --> 00:20:33,639
Speaker 6: Part of that is what we've done on energy.

373
00:20:33,720 --> 00:20:35,600
Speaker 7: And I know it sounds like a strange thing to

374
00:20:35,640 --> 00:20:38,960
Speaker 7: bring in when we're talking about you know, prescription drugs

375
00:20:38,960 --> 00:20:42,320
Speaker 7: and pharmaceuticals, but in order to have manufacturing, you have

376
00:20:42,400 --> 00:20:45,879
Speaker 7: to have energy, and so low cost, affordable, abundant energy

377
00:20:45,920 --> 00:20:49,560
Speaker 7: in the United States is critically important. And those provisions

378
00:20:49,560 --> 00:20:51,679
Speaker 7: that we had in the One Big Beautiful Bill, the

379
00:20:51,760 --> 00:20:55,760
Speaker 7: Reconciliation Bill, to support energy of all sources in the

380
00:20:55,880 --> 00:20:59,399
Speaker 7: United States and so that it's affordable and abundant, I

381
00:20:59,400 --> 00:21:01,640
Speaker 7: think is all so very important to what we're doing

382
00:21:02,000 --> 00:21:06,320
Speaker 7: in on shoring and bringing back manufacturing of pharmaceuticals, especially

383
00:21:06,320 --> 00:21:09,679
Speaker 7: antibiotics and some of those lower cost generic drugs that

384
00:21:09,720 --> 00:21:11,840
Speaker 7: are widely used.

385
00:21:12,040 --> 00:21:14,720
Speaker 6: But you can have run into shortages.

386
00:21:16,000 --> 00:21:19,440
Speaker 1: Yeah, you touch on something that a lot of people

387
00:21:19,480 --> 00:21:21,560
Speaker 1: have a question. You and Center Grassi have been leaders

388
00:21:21,560 --> 00:21:23,840
Speaker 1: on this trying to get the pension of the pharmaceutical

389
00:21:24,080 --> 00:21:26,639
Speaker 1: benefit managers the middleman out of the way or certainly

390
00:21:26,760 --> 00:21:29,760
Speaker 1: from inflating the prices. It's been talked about a lot

391
00:21:29,800 --> 00:21:31,199
Speaker 1: in Congress for a long time. What do you think

392
00:21:31,240 --> 00:21:34,240
Speaker 1: the chances in this next year that gets done.

393
00:21:35,040 --> 00:21:36,920
Speaker 7: I think that it's going to get done within this

394
00:21:37,080 --> 00:21:40,600
Speaker 7: term in Congress, so within the one hundred and nineteenth Congress.

395
00:21:41,040 --> 00:21:44,520
Speaker 7: Remember when I passed my first PBM reform bill in

396
00:21:44,640 --> 00:21:48,440
Speaker 7: twenty nineteen as a state senator, I had to convince people.

397
00:21:48,200 --> 00:21:49,359
Speaker 6: To vote for it.

398
00:21:49,359 --> 00:21:53,000
Speaker 7: It was on the transparency part of it, and pharmacy

399
00:21:53,040 --> 00:21:56,600
Speaker 7: benefit managers have a place in the whole supply chain,

400
00:21:56,960 --> 00:21:59,400
Speaker 7: but right now they have an outsized role. And there

401
00:21:59,520 --> 00:22:03,919
Speaker 7: is you know, consolidation within the industry which the.

402
00:22:04,080 --> 00:22:05,600
Speaker 6: FTC is now looking at.

403
00:22:05,840 --> 00:22:09,560
Speaker 7: But it is a reason why certain medications aren't available,

404
00:22:09,600 --> 00:22:13,200
Speaker 7: why tiers are changed from one year to another, where

405
00:22:13,200 --> 00:22:15,679
Speaker 7: a drug may cost a certain amount and then the

406
00:22:15,720 --> 00:22:19,200
Speaker 7: next year it's two to three times at the rebates

407
00:22:19,200 --> 00:22:21,760
Speaker 7: and administrative fees. It's absolute an era we need to

408
00:22:21,800 --> 00:22:23,919
Speaker 7: look at and we are and I think we're going

409
00:22:24,000 --> 00:22:28,040
Speaker 7: to finally see some legislation and states are now outpacing us.

410
00:22:28,080 --> 00:22:31,040
Speaker 7: As I said, My first bill was in twenty nineteen.

411
00:22:31,840 --> 00:22:33,520
Speaker 7: We see a lot of work on the states, but

412
00:22:33,560 --> 00:22:37,240
Speaker 7: it needs to be federal legislation that addresses this issue.

413
00:22:37,280 --> 00:22:40,320
Speaker 7: And I think it's going to get done before the

414
00:22:40,400 --> 00:22:41,680
Speaker 7: end of twenty twenty six.

415
00:22:42,960 --> 00:22:47,119
Speaker 1: Making America Generics great again, a new form of MAGA.

416
00:22:47,520 --> 00:22:47,960
Speaker 2: How about that.

417
00:22:48,600 --> 00:22:50,080
Speaker 5: Well, to let you go, I want to ask you

418
00:22:50,119 --> 00:22:53,359
Speaker 5: about how most favored nations affect this. Because President Trump

419
00:22:53,400 --> 00:22:55,720
Speaker 5: wants to bring prescription costs down for the American people.

420
00:22:55,760 --> 00:22:58,000
Speaker 5: You said, we have to make sure that we're paying enough.

421
00:22:58,119 --> 00:23:01,919
Speaker 5: So if those costs get brought down for the American people,

422
00:23:02,040 --> 00:23:05,200
Speaker 5: but they are raised for other nations, does it even

423
00:23:05,240 --> 00:23:08,199
Speaker 5: out and neutralize any detriment that it could be to

424
00:23:08,240 --> 00:23:09,520
Speaker 5: the efforts that you're talking about.

425
00:23:10,560 --> 00:23:13,359
Speaker 7: So I think that you're correct in most of the

426
00:23:13,400 --> 00:23:15,719
Speaker 7: things that we do that there's a balancing act. So

427
00:23:15,760 --> 00:23:19,560
Speaker 7: we know that the US has been subsidizing lower cost

428
00:23:20,040 --> 00:23:23,320
Speaker 7: drugs and other places, and the message to the pharmaceutical

429
00:23:23,359 --> 00:23:28,000
Speaker 7: industry is to renegotiate those contracts with foreign countries. We

430
00:23:28,040 --> 00:23:31,720
Speaker 7: want to have robust pharmaceutical development here in the United States.

431
00:23:31,840 --> 00:23:33,720
Speaker 6: That is, as you said.

432
00:23:33,720 --> 00:23:37,320
Speaker 7: The immune suppressing drugs, the drugs that for rare diseases,

433
00:23:37,560 --> 00:23:44,280
Speaker 7: orphan diseases, which the Bide Administration had some unfavorable regulation around.

434
00:23:44,600 --> 00:23:47,639
Speaker 7: We want pharmaceutical industries to be located here in the

435
00:23:47,720 --> 00:23:52,679
Speaker 7: United States, all types of medications and prescription medications. We

436
00:23:52,680 --> 00:23:54,720
Speaker 7: need to keep energy costs low so we can have

437
00:23:54,840 --> 00:23:58,120
Speaker 7: manufacturing here. We're not going to lower labor costs, which

438
00:23:58,160 --> 00:24:00,119
Speaker 7: is one of the things that makes it detrimental. Well,

439
00:24:00,359 --> 00:24:04,480
Speaker 7: having a favoral tax structure, you know, keeping that corporate

440
00:24:04,560 --> 00:24:07,680
Speaker 7: tax rate at twenty one percent instead of it having

441
00:24:07,720 --> 00:24:10,800
Speaker 7: gone up if the Tax Cut and Jobs Act expired

442
00:24:10,840 --> 00:24:12,600
Speaker 7: at the end of the year. All of those things,

443
00:24:12,800 --> 00:24:15,159
Speaker 7: they're all small components which are going to help us

444
00:24:15,160 --> 00:24:17,280
Speaker 7: do that here in the United States. And then that

445
00:24:17,440 --> 00:24:22,040
Speaker 7: balancing act on you know, having cost raised in certain

446
00:24:22,119 --> 00:24:25,679
Speaker 7: other countries and lowered here in the United States, but

447
00:24:25,720 --> 00:24:29,399
Speaker 7: then also continuing to have a robust pharmaceutical market in

448
00:24:29,400 --> 00:24:32,439
Speaker 7: the United States for both you know, other drugs that

449
00:24:32,480 --> 00:24:36,480
Speaker 7: are less commonly used, but also for generics and antabotics here.

450
00:24:36,600 --> 00:24:40,560
Speaker 7: And then testing reagents. Those things I think are all critical.

451
00:24:40,680 --> 00:24:44,160
Speaker 7: They're all critically important. We should not be dependent upon

452
00:24:44,240 --> 00:24:47,320
Speaker 7: other foreign nations in a crisis, and we found that

453
00:24:47,359 --> 00:24:50,600
Speaker 7: we were during COVID and that's some practices that we

454
00:24:50,640 --> 00:24:52,720
Speaker 7: want to end and make sure we have that here

455
00:24:52,760 --> 00:24:53,680
Speaker 7: in the United States.

456
00:24:54,480 --> 00:24:55,159
Speaker 6: We can do it.

457
00:24:55,280 --> 00:24:57,920
Speaker 7: We innovate, we improvise, we adapt, We have a work

458
00:24:58,000 --> 00:25:00,720
Speaker 7: ethic like no other country, and I think here in

459
00:25:00,720 --> 00:25:02,960
Speaker 7: the United States is where we can really get things done.

460
00:25:04,640 --> 00:25:06,199
Speaker 5: Congress, I want to tell you what, whether it is

461
00:25:06,240 --> 00:25:08,480
Speaker 5: the legislative side or the medical side, you are such

462
00:25:08,480 --> 00:25:10,439
Speaker 5: a wealth of information. We are so lucky to have

463
00:25:10,480 --> 00:25:13,119
Speaker 5: you here. Congresswoman Marionette Miller Meeks, thanks so much for

464
00:25:13,160 --> 00:25:13,960
Speaker 5: being with us tonight.

465
00:25:14,680 --> 00:25:15,040
Speaker 6: Thank you.

466
00:25:16,160 --> 00:25:18,520
Speaker 5: Absolutely all right, everybody, We're going to have much more

467
00:25:18,600 --> 00:25:20,160
Speaker 5: for you on this very important topic.

468
00:25:20,200 --> 00:25:26,320
Speaker 1: On the other side of these normals, Hey, folks, if

469
00:25:26,359 --> 00:25:28,359
Speaker 1: your homeowner like me, you need to listen to this.

470
00:25:28,720 --> 00:25:32,360
Speaker 1: In today's AI and CyberWorld, scammers are stealing home titles and.

471
00:25:32,359 --> 00:25:35,600
Speaker 2: Your equity is their target. Here's how it works.

472
00:25:35,680 --> 00:25:38,480
Speaker 1: Criminals forge your signature on one document, use a fake

473
00:25:38,560 --> 00:25:41,359
Speaker 1: notary stamp, pay a small fee with your county in boom.

474
00:25:41,400 --> 00:25:44,160
Speaker 1: Just like that, your home title has been transferred out

475
00:25:44,200 --> 00:25:45,960
Speaker 1: of your name. And that's where the problems begin because

476
00:25:45,960 --> 00:25:48,920
Speaker 1: they start taking out loans using your equity and even

477
00:25:48,920 --> 00:25:50,720
Speaker 1: sell your property and you're not even going to find

478
00:25:50,760 --> 00:25:53,480
Speaker 1: out what's happened until you get a collection or foreclosure

479
00:25:53,520 --> 00:25:54,520
Speaker 1: notice months later.

480
00:25:54,560 --> 00:25:55,240
Speaker 2: That's a nightmare.

481
00:25:55,320 --> 00:25:57,199
Speaker 1: Right, So when's the last time you checked on your

482
00:25:57,240 --> 00:25:59,200
Speaker 1: home title? Well, if you like me, the answer is never.

483
00:25:59,320 --> 00:26:01,560
Speaker 2: Right. Need to do something about that right now.

484
00:26:01,600 --> 00:26:03,879
Speaker 1: That's why I partnered with Home Title Lock so you

485
00:26:03,920 --> 00:26:06,679
Speaker 1: can find out today. If you're already a victim, use

486
00:26:06,760 --> 00:26:10,359
Speaker 1: my promo code JTN at hometitle lock dot com and

487
00:26:10,400 --> 00:26:12,600
Speaker 1: you'll get a free title history report in a free

488
00:26:12,640 --> 00:26:15,840
Speaker 1: trial of their million dollar Triple Lock protection. That's twenty

489
00:26:15,840 --> 00:26:18,520
Speaker 1: four to seven monitoring of your title, urgent alerts to

490
00:26:18,560 --> 00:26:20,919
Speaker 1: any changes that might happen, and if fraud does happen,

491
00:26:21,280 --> 00:26:23,359
Speaker 1: they'll spend up to a million bucks to fix it.

492
00:26:23,400 --> 00:26:24,040
Speaker 2: That's a good deal.

493
00:26:24,359 --> 00:26:26,600
Speaker 1: Find out why I trust home title Lock. Go to

494
00:26:26,680 --> 00:26:29,360
Speaker 1: home title lock dot com and use the promo code JTN.

495
00:26:29,400 --> 00:26:45,880
Speaker 1: That's home titleock dot Com promo code JTN. All right, folks,

496
00:26:45,920 --> 00:26:47,840
Speaker 1: welcome back for the commercial break. I promised at the

497
00:26:47,880 --> 00:26:49,359
Speaker 1: start of the show we'd give you a little taste

498
00:26:49,400 --> 00:26:51,240
Speaker 1: of the future. We're going to gaze at the horizon

499
00:26:51,280 --> 00:26:54,000
Speaker 1: to show you what's possible in the next few months,

500
00:26:54,040 --> 00:26:57,000
Speaker 1: even in America, to south this extraordinary crisis that we

501
00:26:57,080 --> 00:27:00,119
Speaker 1: have for reshoring American drug manufacturing. Joining us now well

502
00:27:00,440 --> 00:27:03,120
Speaker 1: David shuk, co founder of Our gentam, a company looking

503
00:27:03,119 --> 00:27:06,000
Speaker 1: to address the challenges of that reshoring of those important

504
00:27:06,040 --> 00:27:08,280
Speaker 1: drugs that we all take, the antibotics and antivirals, and

505
00:27:08,359 --> 00:27:11,720
Speaker 1: Craig Heenahan, a board member and senior advisor to Our Gentleman,

506
00:27:11,840 --> 00:27:15,040
Speaker 1: also the founder of Red Oak Sourcing, the largest buyer

507
00:27:15,080 --> 00:27:16,719
Speaker 1: of generic drugs in the United States.

508
00:27:16,880 --> 00:27:20,600
Speaker 2: Gentlemen, welcome, good to have you on. Thank you, Greg.

509
00:27:21,000 --> 00:27:22,120
Speaker 2: I want to start with you.

510
00:27:21,960 --> 00:27:24,560
Speaker 1: You are in a fascinating position because you're on both

511
00:27:24,600 --> 00:27:27,520
Speaker 1: sides of this very important solution. That one side, you're

512
00:27:27,800 --> 00:27:30,320
Speaker 1: consuming and buying the generic drugs. On the other side,

513
00:27:30,359 --> 00:27:33,439
Speaker 1: you're helping to create a short and long term solution

514
00:27:33,520 --> 00:27:36,480
Speaker 1: to make sure we can reshore this important manufacturing line

515
00:27:36,520 --> 00:27:39,439
Speaker 1: to America. Tell us, how did we get to this

516
00:27:39,560 --> 00:27:42,840
Speaker 1: point where the most common drugs we all use, the generics,

517
00:27:43,000 --> 00:27:46,200
Speaker 1: the antibiotics, were basically outsourced out of our country.

518
00:27:47,160 --> 00:27:49,560
Speaker 8: Well, if you think about it, ninety percent of all

519
00:27:49,640 --> 00:27:53,520
Speaker 8: prescription drugs in the US are generic pharmaceuticals, and the

520
00:27:53,520 --> 00:27:57,439
Speaker 8: sociat of generic pharmaceutical is really a global endeavor, and

521
00:27:57,480 --> 00:28:01,600
Speaker 8: so it's highly complex the sourcing of it with a

522
00:28:01,760 --> 00:28:04,880
Speaker 8: number of processes, whether it be around the approval process

523
00:28:04,960 --> 00:28:09,840
Speaker 8: right the manufacturing process, or the distribution process. And if

524
00:28:09,880 --> 00:28:11,320
Speaker 8: you know, if you want to think about it this way,

525
00:28:11,400 --> 00:28:15,040
Speaker 8: like if we were sourcing a drug outside the US

526
00:28:15,119 --> 00:28:19,239
Speaker 8: that was a single source in our econmocal in that

527
00:28:19,320 --> 00:28:23,119
Speaker 8: country for whatever reason halted the shipment of that product,

528
00:28:23,440 --> 00:28:26,600
Speaker 8: I would estimate that within eight to sixteen weeks we

529
00:28:26,640 --> 00:28:29,080
Speaker 8: would be out of stock of that product and that

530
00:28:29,200 --> 00:28:31,000
Speaker 8: patients trying to get the medication.

531
00:28:30,640 --> 00:28:32,120
Speaker 3: Would be having a very difficult time.

532
00:28:32,400 --> 00:28:34,200
Speaker 2: Wow. So a lot of a lot of the.

533
00:28:34,200 --> 00:28:38,560
Speaker 8: Manufacturing as well as the API manufacturing is all done

534
00:28:38,640 --> 00:28:39,640
Speaker 8: outside the US.

535
00:28:40,160 --> 00:28:44,480
Speaker 2: WHOA wow, Wow, that's it eight sixteen weeks. That's scary.

536
00:28:44,600 --> 00:28:46,720
Speaker 5: David, I want to ask you, because our gentleman is

537
00:28:46,760 --> 00:28:49,960
Speaker 5: obviously already doing a great job, but when it comes

538
00:28:50,000 --> 00:28:53,800
Speaker 5: to regulation for you to do your job better to

539
00:28:53,840 --> 00:28:56,400
Speaker 5: provide more drugs for the American people. For you to

540
00:28:56,440 --> 00:28:58,920
Speaker 5: do that, how what needs to happen as far as

541
00:28:59,000 --> 00:29:02,120
Speaker 5: regulation or is this administration have they already stripped away

542
00:29:02,200 --> 00:29:04,800
Speaker 5: enough such that you can really ramp it up.

543
00:29:06,560 --> 00:29:09,760
Speaker 9: So thank you for having us on. I really appreciate

544
00:29:09,800 --> 00:29:12,520
Speaker 9: it and letting us maybe say a few words about

545
00:29:12,560 --> 00:29:15,440
Speaker 9: our company. So our Gentom is, you know, one of

546
00:29:15,480 --> 00:29:21,080
Speaker 9: the only true US based and US owned generic drug

547
00:29:21,120 --> 00:29:23,920
Speaker 9: companies in the United States. Since we founded the company

548
00:29:23,920 --> 00:29:27,360
Speaker 9: in twenty fifteen, we've worked to obtain a number of

549
00:29:27,360 --> 00:29:31,520
Speaker 9: settlements with several branded drug companies. These settlements allow us

550
00:29:31,560 --> 00:29:34,760
Speaker 9: to enter certain generic markets with a generic form of

551
00:29:34,800 --> 00:29:37,080
Speaker 9: a drug once it goes off patent, and that is

552
00:29:37,120 --> 00:29:41,120
Speaker 9: our business today. However, along the way, as we've built

553
00:29:41,120 --> 00:29:43,920
Speaker 9: the company, Our Gentom has has sort of come to

554
00:29:44,000 --> 00:29:50,760
Speaker 9: realize just how hollowed out our generic drug manufacturing industry

555
00:29:51,080 --> 00:29:54,360
Speaker 9: has become here in the United States. Over several decades,

556
00:29:54,400 --> 00:29:57,720
Speaker 9: we've recognized this to be a real concern for the country,

557
00:29:57,800 --> 00:30:02,520
Speaker 9: something which should be as strategic national interest. Hundreds of

558
00:30:02,520 --> 00:30:07,840
Speaker 9: the most important drugs used for in hospitals, antibiotics, blood

559
00:30:07,840 --> 00:30:12,400
Speaker 9: pressure medications, they're just not made here. They're largely made

560
00:30:12,480 --> 00:30:15,400
Speaker 9: in Asia and that, and we believe that some of

561
00:30:15,440 --> 00:30:20,440
Speaker 9: these drugs should to a certain extent be resored, meaning

562
00:30:20,480 --> 00:30:23,600
Speaker 9: that investment should take place to bring some of this

563
00:30:23,840 --> 00:30:28,880
Speaker 9: manufacturing back to the US, both finished dosage drugs and

564
00:30:28,960 --> 00:30:32,120
Speaker 9: the APIs that go into making those finished dose products.

565
00:30:32,120 --> 00:30:34,960
Speaker 9: So we've been working with a number of partners and

566
00:30:35,040 --> 00:30:39,360
Speaker 9: investing our own capital into addressing this problem, and we

567
00:30:39,360 --> 00:30:41,320
Speaker 9: we would like to be and plan to be an

568
00:30:41,360 --> 00:30:44,320
Speaker 9: important part of the long term solution to this. And

569
00:30:44,440 --> 00:30:47,800
Speaker 9: just to get back to answering your question, Uh, you

570
00:30:47,840 --> 00:30:51,440
Speaker 9: know the administration, the EO that came out, it's incredibly

571
00:30:51,520 --> 00:30:55,600
Speaker 9: encouraging to see that. We want to see more interest

572
00:30:56,240 --> 00:30:59,920
Speaker 9: in this problem. We think it is a hugely import

573
00:31:00,440 --> 00:31:04,520
Speaker 9: national concern, and their Dentium plans to be a big

574
00:31:04,560 --> 00:31:06,360
Speaker 9: part of coming up with that long term solution.

575
00:31:07,000 --> 00:31:08,720
Speaker 2: It's so amazing. All right.

576
00:31:08,800 --> 00:31:11,000
Speaker 1: So we know that to buy or to build a

577
00:31:11,040 --> 00:31:13,520
Speaker 1: big brick and mortar factory that has large scale it's

578
00:31:13,560 --> 00:31:15,160
Speaker 1: kind of take two to five years with all the

579
00:31:15,200 --> 00:31:17,800
Speaker 1: things that go into building a factory, staffing, en up, permitting,

580
00:31:17,800 --> 00:31:21,280
Speaker 1: et cetera. You have some pretty remarkable solutions that fit

581
00:31:21,400 --> 00:31:23,840
Speaker 1: in like an office space or a little small building.

582
00:31:24,240 --> 00:31:27,040
Speaker 1: Tell us tell us about what that could do short

583
00:31:27,120 --> 00:31:29,840
Speaker 1: term to fill up our supply before those big factories

584
00:31:29,840 --> 00:31:30,280
Speaker 1: get rowed.

585
00:31:31,480 --> 00:31:31,680
Speaker 2: Yeah.

586
00:31:31,720 --> 00:31:33,640
Speaker 9: I mean the way that we think about this is

587
00:31:33,680 --> 00:31:37,920
Speaker 9: that there's really two phases to addressing this issue.

588
00:31:37,960 --> 00:31:38,840
Speaker 2: And and and.

589
00:31:38,880 --> 00:31:42,080
Speaker 9: One would be to maybe look at, you know, there

590
00:31:42,080 --> 00:31:46,040
Speaker 9: are in the United States some strategic stock piles of

591
00:31:46,200 --> 00:31:49,920
Speaker 9: certain of you know, PPE and other healthcare equipment and

592
00:31:50,000 --> 00:31:53,960
Speaker 9: some some drugs. But one thing that we would like

593
00:31:54,000 --> 00:31:58,640
Speaker 9: to be involved in is building a larger, more lasting,

594
00:31:59,000 --> 00:32:05,760
Speaker 9: strategic result of many different medications across many different therapeutic areas.

595
00:32:06,800 --> 00:32:10,560
Speaker 9: And this could be This could be done for just

596
00:32:10,600 --> 00:32:12,840
Speaker 9: the US military or the Defense Department. It could be

597
00:32:12,880 --> 00:32:15,240
Speaker 9: done on a state by state basis, it could be

598
00:32:15,280 --> 00:32:19,280
Speaker 9: done on a nationwide basis, taking a percentage of the

599
00:32:19,360 --> 00:32:22,719
Speaker 9: use of those products over a year and focusing on

600
00:32:22,760 --> 00:32:26,200
Speaker 9: that as a stockpile. That stockpiling would be what we

601
00:32:26,200 --> 00:32:29,360
Speaker 9: would consider it to be phase one. Phase two would

602
00:32:29,400 --> 00:32:35,760
Speaker 9: be building a new, next generation continuous manufacturing of some

603
00:32:35,800 --> 00:32:38,920
Speaker 9: of these products. A lot of these generic drugs that

604
00:32:38,960 --> 00:32:42,520
Speaker 9: are so critical to the health and well being of

605
00:32:42,800 --> 00:32:46,360
Speaker 9: millions of Americans are our drugs that are actually quite

606
00:32:46,400 --> 00:32:51,080
Speaker 9: easy to manufacture. They've been manufactured for decades, and there

607
00:32:51,120 --> 00:32:53,000
Speaker 9: are a lot of I mean, we don't have a

608
00:32:53,040 --> 00:32:54,480
Speaker 9: lot of time to go into it. But there are

609
00:32:55,600 --> 00:33:04,000
Speaker 9: some really incredible new new technology around manufacturing pharmaceutical products

610
00:33:04,120 --> 00:33:07,800
Speaker 9: very quickly and as you said, a very small space.

611
00:33:07,920 --> 00:33:11,280
Speaker 9: This does not have to be to make a drug

612
00:33:11,320 --> 00:33:15,640
Speaker 9: that is enough supply for an entire year. You really

613
00:33:15,680 --> 00:33:18,800
Speaker 9: don't need an enormous factory to do that anymore.

614
00:33:19,600 --> 00:33:21,200
Speaker 2: That's amazing, amazing.

615
00:33:21,480 --> 00:33:23,719
Speaker 5: Before we let you guys go, Craig, I know at

616
00:33:24,120 --> 00:33:27,000
Speaker 5: red Oak, you guys are the largest buyer of generic

617
00:33:27,080 --> 00:33:28,600
Speaker 5: drugs in the United States.

618
00:33:28,840 --> 00:33:29,440
Speaker 6: When you are.

619
00:33:29,360 --> 00:33:31,760
Speaker 5: Sourcing these drugs from I mean we've already been talking

620
00:33:31,760 --> 00:33:34,240
Speaker 5: about it, China and India most likely. What are the

621
00:33:34,240 --> 00:33:37,600
Speaker 5: biggest issues that you run into? Is it quality control?

622
00:33:37,640 --> 00:33:41,400
Speaker 5: As far as contamination? Is it, you know, improper orders fulfilled?

623
00:33:41,440 --> 00:33:43,240
Speaker 5: What's the biggest issue you run into with them?

624
00:33:43,920 --> 00:33:46,400
Speaker 8: No, well, you know, I left red Olick back in

625
00:33:46,400 --> 00:33:49,120
Speaker 8: twenty sixteen, but when I was there, the things that

626
00:33:49,240 --> 00:33:51,920
Speaker 8: kept me up at night were really the continuity of supply.

627
00:33:52,600 --> 00:33:55,200
Speaker 8: So it was you know, making sure that we had

628
00:33:55,200 --> 00:33:58,640
Speaker 8: the product that our patients were going to need and

629
00:33:59,040 --> 00:34:02,920
Speaker 8: they're with their and so price for you, so always say, yeah,

630
00:34:02,960 --> 00:34:04,760
Speaker 8: we may unwrestle over price, but if you don't have

631
00:34:04,760 --> 00:34:06,760
Speaker 8: the product that doesn't do you any good, So that

632
00:34:06,800 --> 00:34:09,280
Speaker 8: would be the number one concern as far as safety

633
00:34:09,320 --> 00:34:12,240
Speaker 8: and efficacy. You know, we relied heavily upon the FDA

634
00:34:13,920 --> 00:34:17,000
Speaker 8: to ensure that the products that we are sourcing were

635
00:34:18,239 --> 00:34:19,880
Speaker 8: safe and effective for the patients.

636
00:34:20,480 --> 00:34:22,960
Speaker 1: So amazing, David. One last quick one that we got

637
00:34:22,960 --> 00:34:24,920
Speaker 1: to go, But I want to ask. It seems as

638
00:34:24,960 --> 00:34:26,840
Speaker 1: though that you could take a bunch of these micro

639
00:34:28,040 --> 00:34:30,920
Speaker 1: processing plants that are now this new age of innovation,

640
00:34:31,320 --> 00:34:34,200
Speaker 1: string them together and get a large scale pretty quickly,

641
00:34:34,640 --> 00:34:36,719
Speaker 1: even before a factory could come up. Is that maybe

642
00:34:36,760 --> 00:34:40,400
Speaker 1: a way of re envisioning manufacturing even on the grander scale.

643
00:34:40,880 --> 00:34:45,719
Speaker 9: We think it is absolutely Is that happening right now?

644
00:34:45,880 --> 00:34:45,920
Speaker 10: No?

645
00:34:46,239 --> 00:34:49,359
Speaker 9: Is it possible for them to be happening two years

646
00:34:49,400 --> 00:34:54,800
Speaker 9: from now? Absolutely? You know, so we want to be

647
00:34:54,880 --> 00:34:58,360
Speaker 9: very much involved in this. I think that it is

648
00:34:58,480 --> 00:35:01,520
Speaker 9: going to be a collective effort of a number of

649
00:35:01,680 --> 00:35:06,279
Speaker 9: companies that are US based, US owned companies, and our

650
00:35:06,320 --> 00:35:08,400
Speaker 9: gentlem plans to be a big part of this.

651
00:35:09,160 --> 00:35:11,200
Speaker 2: Of this effort that's so huge.

652
00:35:11,280 --> 00:35:13,040
Speaker 1: I think both of you, gentlemen, are going to play

653
00:35:13,040 --> 00:35:14,880
Speaker 1: a major, major role in what's going to be a

654
00:35:15,000 --> 00:35:18,719
Speaker 1: history changing innovative moment in American manufacturing. It's a great

655
00:35:18,760 --> 00:35:20,360
Speaker 1: honor to have you on the show, gentlemen, thanks for

656
00:35:20,480 --> 00:35:21,120
Speaker 1: joining us today.

657
00:35:21,640 --> 00:35:22,479
Speaker 9: It's another beer.

658
00:35:22,800 --> 00:35:25,200
Speaker 2: Yeah, wow, great, what a great conversation. What's you great? Men?

659
00:35:25,400 --> 00:35:27,120
Speaker 2: All right, folks, were gonn take a quick comercial break.

660
00:35:27,160 --> 00:35:28,600
Speaker 1: When we come back, We're going to wrap up with

661
00:35:28,640 --> 00:35:31,399
Speaker 1: some more conversations on this topic with a man who

662
00:35:31,520 --> 00:35:34,160
Speaker 1: just met some with some of HHS sufficials to talk

663
00:35:34,200 --> 00:35:36,560
Speaker 1: about this very issue you had him on before. He's

664
00:35:36,560 --> 00:35:38,920
Speaker 1: a retired colonel one of our favorites, Vick Warz. Right

665
00:35:38,920 --> 00:35:40,120
Speaker 1: after the commercial break.

666
00:35:43,760 --> 00:35:50,600
Speaker 11: Than he ran Family and war Room posse. Mark your camad.

667
00:35:51,800 --> 00:35:56,080
Speaker 11: September twelfth and thirteenth, the Rebels, Robes and Outlaws Tour

668
00:35:56,520 --> 00:35:58,759
Speaker 11: is coming to the America First Warehouse.

669
00:35:58,920 --> 00:35:59,960
Speaker 3: I have never seen anything like that.

670
00:36:00,320 --> 00:36:04,840
Speaker 11: Two unforgettable days filled with Patriots, barbecue and live shows

671
00:36:04,880 --> 00:36:09,080
Speaker 11: straight from the most amazing place, the America First Warehouse.

672
00:36:09,400 --> 00:36:12,280
Speaker 11: Get ready for a special guest to be announced, plus

673
00:36:12,320 --> 00:36:15,040
Speaker 11: a three hour live episode of Studios six B.

674
00:36:15,239 --> 00:36:16,399
Speaker 2: And we're just going to go do it.

675
00:36:16,520 --> 00:36:19,240
Speaker 11: On the twelfth, Steve Bannon will host war Room Live

676
00:36:19,320 --> 00:36:22,520
Speaker 11: at five PM and Steve will be back again on

677
00:36:22,600 --> 00:36:26,800
Speaker 11: the thirteenth, followed by one hour with Peter Navarro.

678
00:36:26,640 --> 00:36:27,680
Speaker 3: I went to prison.

679
00:36:27,800 --> 00:36:32,120
Speaker 11: So Long Half the Rebels, Rogues and Outlaws tour September

680
00:36:32,200 --> 00:36:35,400
Speaker 11: twelfth and thirteenth at the America First Warehouse. Scan the

681
00:36:35,480 --> 00:36:40,040
Speaker 11: qr CO to see pricing and availability. Don't miss this opportunity.

682
00:36:40,160 --> 00:36:43,440
Speaker 11: Tickets won't last.

683
00:36:52,200 --> 00:36:54,959
Speaker 5: Welcome back everybody to this very special edition of Justin News,

684
00:36:54,960 --> 00:36:58,480
Speaker 5: No Noise. We are talking all about America's pharmaceutical industry

685
00:36:58,760 --> 00:37:00,480
Speaker 5: and the steps that we need to so that we

686
00:37:00,560 --> 00:37:04,040
Speaker 5: aren't dependent on foreign countries for some very crucial medications.

687
00:37:04,040 --> 00:37:06,000
Speaker 5: So joining us now with someone who knows about this

688
00:37:06,080 --> 00:37:08,919
Speaker 5: problem very well. He's a retired Army colonel and now

689
00:37:09,000 --> 00:37:11,200
Speaker 5: is the founder and principal growth partner at Blue Zone

690
00:37:11,239 --> 00:37:15,960
Speaker 5: Bioscience and Supply Chain Solutions. Back on April thirtieth, twenty

691
00:37:15,960 --> 00:37:18,839
Speaker 5: twenty four, he appeared before the Senate Armed Services Subcommittee

692
00:37:18,880 --> 00:37:22,280
Speaker 5: on Personnel, and his focus was holding the Pentagon accountable

693
00:37:22,360 --> 00:37:25,960
Speaker 5: for making sure our service members get safe, high quality medications.

694
00:37:26,000 --> 00:37:28,960
Speaker 5: Vic Suarez, Vic, thanks so much for being back with us.

695
00:37:29,680 --> 00:37:32,080
Speaker 12: It's pleasure to be back. Hello, Amanda and John.

696
00:37:32,360 --> 00:37:35,520
Speaker 5: Thank you great to have you and this is a

697
00:37:35,560 --> 00:37:39,400
Speaker 5: forward looking conversation, but for those who missed our previous conversations,

698
00:37:39,440 --> 00:37:42,759
Speaker 5: you gave us some harrowing information about some supplies and

699
00:37:42,840 --> 00:37:45,360
Speaker 5: drugs that were desperately needed on some of our bases

700
00:37:45,520 --> 00:37:48,440
Speaker 5: where our service members work. And I just want you

701
00:37:48,480 --> 00:37:51,239
Speaker 5: to recount that a little bit, just a few minutes worth,

702
00:37:51,280 --> 00:37:53,359
Speaker 5: for our audience before we get into what we should

703
00:37:53,400 --> 00:37:54,000
Speaker 5: be doing next.

704
00:37:54,800 --> 00:37:56,520
Speaker 12: Sure thing, a couple of years ago, when I was

705
00:37:56,600 --> 00:37:58,920
Speaker 12: on active duty, I was in a pretty senior position

706
00:37:59,040 --> 00:38:02,400
Speaker 12: managing kind of a global supply chain of pharmaceuticals, medsarge items,

707
00:38:02,400 --> 00:38:05,239
Speaker 12: and I saw a real big vulnerability over the last

708
00:38:05,239 --> 00:38:09,480
Speaker 12: several years, specifically from a national security perspective, where we

709
00:38:09,480 --> 00:38:13,360
Speaker 12: weren't our formations, our special forces units, or our frontline

710
00:38:13,440 --> 00:38:17,200
Speaker 12: units were not able to get basic medicines that would

711
00:38:17,200 --> 00:38:20,400
Speaker 12: be needed for trauma care on the far forward areas.

712
00:38:20,880 --> 00:38:23,879
Speaker 12: And this is not something I saw fifteen twenty years

713
00:38:23,880 --> 00:38:26,080
Speaker 12: ago at the early part of my career, and so

714
00:38:26,160 --> 00:38:28,719
Speaker 12: I started looking into it more and I started to

715
00:38:28,719 --> 00:38:33,200
Speaker 12: see that our global dependence on avasaro nations and strategic

716
00:38:33,200 --> 00:38:35,799
Speaker 12: competitors has led to this problem now where we can't

717
00:38:35,800 --> 00:38:38,480
Speaker 12: even get basic medicines for trauma care.

718
00:38:39,480 --> 00:38:43,120
Speaker 2: Wow, that's just stunning. It's just stunning. You were a

719
00:38:43,200 --> 00:38:43,799
Speaker 2: lot of the people.

720
00:38:43,840 --> 00:38:45,439
Speaker 1: I've done a lot of reporting on this last couple

721
00:38:45,480 --> 00:38:47,400
Speaker 1: of months, and a lot of people say you were

722
00:38:47,440 --> 00:38:50,040
Speaker 1: the most important siren that when you gave that testimony

723
00:38:50,040 --> 00:38:52,759
Speaker 1: to Congress, people were shocked. So much has happened. We've

724
00:38:52,760 --> 00:38:55,279
Speaker 1: got the executive Order. I think you were meeting in

725
00:38:55,320 --> 00:38:58,080
Speaker 1: the last few days with folks at the Trump Aths.

726
00:38:58,120 --> 00:39:00,000
Speaker 1: Tell us what you're learning on the inside of where

727
00:39:00,080 --> 00:39:01,320
Speaker 1: they're moving this next.

728
00:39:02,000 --> 00:39:03,520
Speaker 12: Yeah, So I think there's a lot of excitement, and

729
00:39:03,520 --> 00:39:07,120
Speaker 12: buzz I was meeting with some officials yesterday here in

730
00:39:07,120 --> 00:39:10,640
Speaker 12: the area. And really the next steps is that they

731
00:39:10,640 --> 00:39:12,600
Speaker 12: have the charge on their John Knox's team to really

732
00:39:12,640 --> 00:39:16,040
Speaker 12: implement this new executive Order. And some of the exciting

733
00:39:16,080 --> 00:39:19,799
Speaker 12: things that they're working on is they're working with industry

734
00:39:20,320 --> 00:39:22,200
Speaker 12: And I was in a room yesterday with like twenty

735
00:39:22,320 --> 00:39:27,000
Speaker 12: or thirty industry reps working with the government team under

736
00:39:27,080 --> 00:39:31,759
Speaker 12: John Knox to identify capabilities and performers that could use

737
00:39:31,800 --> 00:39:35,640
Speaker 12: next generation technology. So we're talking about advanced manufacturing technology,

738
00:39:35,960 --> 00:39:41,680
Speaker 12: continuous flow technology, and on demand manufacturing capabilities that really

739
00:39:41,800 --> 00:39:45,200
Speaker 12: is really the next horizon. To save a lot of

740
00:39:45,200 --> 00:39:47,239
Speaker 12: costs in the manufacturing, gives us US a lot more

741
00:39:47,280 --> 00:39:51,320
Speaker 12: strategic flexibility of where we make these medicines, but also

742
00:39:51,840 --> 00:39:54,760
Speaker 12: shifts us away from where the Chinese and the Indians

743
00:39:55,360 --> 00:39:58,840
Speaker 12: and their manufacturers have caused a lot of quality issues,

744
00:39:58,840 --> 00:40:00,000
Speaker 12: and that's old chemical sins.

745
00:40:00,080 --> 00:40:00,760
Speaker 2: This is methods.

746
00:40:00,760 --> 00:40:04,880
Speaker 12: It uses a lot of toxic solvents and certain reagents

747
00:40:04,880 --> 00:40:06,759
Speaker 12: that are not of the highest quality. And we can

748
00:40:06,920 --> 00:40:11,000
Speaker 12: pivot that to continuous manufacturing where we can produce higher

749
00:40:11,080 --> 00:40:15,080
Speaker 12: quality yields of some of these medicines. But we're starting

750
00:40:15,080 --> 00:40:17,600
Speaker 12: to see that right now. There's again over twenty people

751
00:40:17,640 --> 00:40:20,000
Speaker 12: in the room, and so I think it's a good sign,

752
00:40:20,280 --> 00:40:22,600
Speaker 12: and some of the folks that are on Johnnox's team

753
00:40:22,640 --> 00:40:27,759
Speaker 12: are pretty motivated and excited to press this forward with industry.

754
00:40:28,000 --> 00:40:30,520
Speaker 5: And just to bring the direness of this situation into

755
00:40:30,560 --> 00:40:34,400
Speaker 5: the conversation. You know, oftentimes when we're talking about mineral mining,

756
00:40:34,480 --> 00:40:37,440
Speaker 5: especially with respect to China, we're thinking about technology. But

757
00:40:37,520 --> 00:40:40,359
Speaker 5: that trickles down into the pharmaceutical industry as well, doesn't it.

758
00:40:41,080 --> 00:40:43,080
Speaker 12: Yes, I mean there's a good number of medicines that

759
00:40:43,160 --> 00:40:46,080
Speaker 12: rely on critical minerals. I mean, if you think about

760
00:40:46,600 --> 00:40:49,759
Speaker 12: the chemistry table you saw in high school, A lot

761
00:40:49,800 --> 00:40:56,000
Speaker 12: of those I mean, think about man magnesium, calcium, potassium,

762
00:40:56,080 --> 00:40:58,160
Speaker 12: A lot of those are actually used in our critical

763
00:40:58,200 --> 00:41:01,799
Speaker 12: medicines every day. And if they're not purified, or we

764
00:41:01,840 --> 00:41:05,239
Speaker 12: can't access them in our most purest form, or we

765
00:41:05,239 --> 00:41:08,279
Speaker 12: can't even access them to begin with because we don't

766
00:41:08,280 --> 00:41:12,640
Speaker 12: have any access to the minds, that becomes a critical

767
00:41:12,760 --> 00:41:16,480
Speaker 12: choke point upstream in the pharmaceutical supply chain. So there

768
00:41:16,520 --> 00:41:19,839
Speaker 12: is a lot of crossover between the topic of you know,

769
00:41:20,040 --> 00:41:22,759
Speaker 12: critical minds and minerals and what we have for our

770
00:41:22,800 --> 00:41:25,680
Speaker 12: health system here in the United States.

771
00:41:25,760 --> 00:41:27,280
Speaker 2: Huge, that's amazing.

772
00:41:28,320 --> 00:41:30,720
Speaker 1: Last time you're on you gave us a little vision

773
00:41:30,760 --> 00:41:32,560
Speaker 1: of what's over that horizon for us.

774
00:41:33,080 --> 00:41:35,400
Speaker 2: With artificial intelligence.

775
00:41:35,160 --> 00:41:38,440
Speaker 1: It's possible that why we build these super size manufacturing

776
00:41:38,440 --> 00:41:42,600
Speaker 1: and make a generic production again large scale in the

777
00:41:42,640 --> 00:41:46,279
Speaker 1: short term, there are small footprint manufacturing facilities driven by

778
00:41:46,360 --> 00:41:49,240
Speaker 1: technology and AI that can get the process going before

779
00:41:49,239 --> 00:41:51,319
Speaker 1: those big plants are operational. Tell us a little bit

780
00:41:51,360 --> 00:41:53,760
Speaker 1: more about what you're seeing develop on that front.

781
00:41:54,640 --> 00:41:56,720
Speaker 12: Yeah, so what we're seeing and I can tell you

782
00:41:56,719 --> 00:41:58,719
Speaker 12: you know, we're seeing this at the university level, which

783
00:41:58,760 --> 00:42:01,400
Speaker 12: is exciting as some of the you know, pharmaceutical sciences

784
00:42:01,440 --> 00:42:04,239
Speaker 12: programs we're seeing in an industry now with a couple

785
00:42:04,200 --> 00:42:07,239
Speaker 12: of companies that are focused on on demand manufacturing devices.

786
00:42:07,480 --> 00:42:10,080
Speaker 12: Think about this something the size of like an hp

787
00:42:10,320 --> 00:42:14,879
Speaker 12: printer chain together in a closed system that can fit

788
00:42:14,960 --> 00:42:19,040
Speaker 12: on a typical desktop, that can make a critical medicine

789
00:42:19,080 --> 00:42:23,200
Speaker 12: within hours, and for quantities that could be as small

790
00:42:23,239 --> 00:42:26,000
Speaker 12: as for individual patient care in what we would call

791
00:42:26,120 --> 00:42:29,240
Speaker 12: precision health or precision medicine, all the way to small

792
00:42:29,320 --> 00:42:32,680
Speaker 12: scale for the thousands, and do this in places that

793
00:42:32,800 --> 00:42:36,360
Speaker 12: would cost only a few hundred thousand dollars to install

794
00:42:36,760 --> 00:42:39,360
Speaker 12: versus hundreds of millions of dollars to build in a

795
00:42:39,360 --> 00:42:42,040
Speaker 12: manufacturing capability. And so one of the things we saw

796
00:42:42,120 --> 00:42:46,480
Speaker 12: yesterday was a call out from the federal team to

797
00:42:46,600 --> 00:42:50,000
Speaker 12: also not only make this, you know, from a generic

798
00:42:50,000 --> 00:42:55,520
Speaker 12: pharmaceutical standpoint for small molecule drugs like the chemical drugs,

799
00:42:55,520 --> 00:42:57,520
Speaker 12: the tablets and the pills that most people are used to,

800
00:42:57,880 --> 00:43:01,480
Speaker 12: but also a program to launch to make this for biologics,

801
00:43:01,680 --> 00:43:06,520
Speaker 12: protein type you know, biologics for critical therapies or even

802
00:43:06,600 --> 00:43:09,719
Speaker 12: vaccines in the future. So that's some of the things

803
00:43:09,760 --> 00:43:11,640
Speaker 12: that are right on the horizon right now. And there

804
00:43:11,640 --> 00:43:15,160
Speaker 12: are companies out there that are going after this technology.

805
00:43:15,680 --> 00:43:18,240
Speaker 2: Yeah, one of them. That's pretty exciting.

806
00:43:18,480 --> 00:43:20,960
Speaker 5: Think it sounds like this with this this HP printer

807
00:43:20,960 --> 00:43:23,640
Speaker 5: that you were talking about, is basically a compounding pharmacy

808
00:43:23,719 --> 00:43:24,320
Speaker 5: on your.

809
00:43:24,200 --> 00:43:25,160
Speaker 6: Desk, Is that right?

810
00:43:26,320 --> 00:43:28,960
Speaker 12: Typically that that's what it is. It's taking what you

811
00:43:28,960 --> 00:43:31,440
Speaker 12: would see in a compounding pharmacy that's done manually.

812
00:43:31,560 --> 00:43:31,960
Speaker 2: Okay.

813
00:43:32,280 --> 00:43:34,640
Speaker 12: Uh, the old you know, the old methods of kind

814
00:43:34,640 --> 00:43:38,120
Speaker 12: of crushing the medicine and then and then putting in

815
00:43:38,160 --> 00:43:38,760
Speaker 12: a capsule.

816
00:43:39,200 --> 00:43:39,560
Speaker 2: Uh.

817
00:43:39,760 --> 00:43:42,960
Speaker 12: That we have machines now by the aid of computers

818
00:43:42,960 --> 00:43:44,799
Speaker 12: that can be very precise with a lot of the

819
00:43:44,840 --> 00:43:48,800
Speaker 12: in the process what we call process analytic technology that

820
00:43:48,880 --> 00:43:52,279
Speaker 12: can actually measure the quality and the actual content of

821
00:43:52,320 --> 00:43:54,160
Speaker 12: the drug that's in there in real time.

822
00:43:54,440 --> 00:43:56,359
Speaker 5: Thank you so much for blowing the whistle on this.

823
00:43:56,440 --> 00:43:58,160
Speaker 5: We have loved having you on. We'll have you back

824
00:43:58,160 --> 00:44:01,000
Speaker 5: on again. I'm sure to stay on this topic. Vik Suarez,

825
00:44:01,080 --> 00:44:04,080
Speaker 5: retired Army colonel and the founder and principal growth partner

826
00:44:04,120 --> 00:44:07,040
Speaker 5: over at Blue Zone Bioscience and Supply Chain Solutions. Thanks

827
00:44:07,080 --> 00:44:09,440
Speaker 5: so much for being with us again tonight, VIC and

828
00:44:09,480 --> 00:44:11,960
Speaker 5: some final thoughts from the both of us after this break.

829
00:44:23,239 --> 00:44:24,280
Speaker 6: Welcome back, everybody.

830
00:44:24,280 --> 00:44:26,240
Speaker 5: We want to close with a piece of an interview

831
00:44:26,360 --> 00:44:29,320
Speaker 5: that we did last night, because sometimes you have questions

832
00:44:29,320 --> 00:44:31,080
Speaker 5: and you get answers that are so important.

833
00:44:31,120 --> 00:44:32,000
Speaker 6: So we want to use.

834
00:44:31,920 --> 00:44:34,799
Speaker 5: Some of that from last night with Congressman Marine Corps

835
00:44:34,840 --> 00:44:37,319
Speaker 5: veteran and he's also a doctor, which is why he's perfect.

836
00:44:37,040 --> 00:44:38,440
Speaker 6: To be here to talk with the S and D

837
00:44:38,560 --> 00:44:40,680
Speaker 6: and overachievers. Resume is about as long as my leg,

838
00:44:40,680 --> 00:44:41,640
Speaker 6: which actually not that long.

839
00:44:41,680 --> 00:44:43,920
Speaker 5: It is a lot longer for his resume, all right, everybody,

840
00:44:43,920 --> 00:44:46,520
Speaker 5: So we're going to play this piece of our interview

841
00:44:46,520 --> 00:44:48,120
Speaker 5: with Congressman Rich McCormick.

842
00:44:48,200 --> 00:44:48,439
Speaker 6: Enjoy.

843
00:44:48,760 --> 00:44:51,760
Speaker 1: We knew coming out of COVID that this was a weakness.

844
00:44:51,800 --> 00:44:54,200
Speaker 1: We saw it in real time during the pandemic, and

845
00:44:54,239 --> 00:44:57,640
Speaker 1: then Joe Biden's team did nothing. Now President Trump's gotten in,

846
00:44:57,719 --> 00:44:59,880
Speaker 1: he's got an executive order, they're ramping up their ref

847
00:45:00,000 --> 00:45:03,120
Speaker 1: filling the supply chain. It seems like the next big

848
00:45:03,160 --> 00:45:06,440
Speaker 1: opportunity is figuring out how to ramp up manufacturing in phases.

849
00:45:06,680 --> 00:45:08,520
Speaker 1: It takes a while to build a big factory, but

850
00:45:08,600 --> 00:45:11,680
Speaker 1: there are these micro factories in technology now that can

851
00:45:11,680 --> 00:45:13,120
Speaker 1: make some drugs quicker and faster.

852
00:45:13,760 --> 00:45:15,560
Speaker 2: Tell us what Congress is doing to try to push

853
00:45:15,600 --> 00:45:17,040
Speaker 2: that along. Well.

854
00:45:17,080 --> 00:45:19,800
Speaker 10: First of all, the kind of Maiden in America initiatives

855
00:45:19,800 --> 00:45:23,720
Speaker 10: that President Trump has been pushing to get production here

856
00:45:23,760 --> 00:45:25,480
Speaker 10: in the United States so it can't be cut off,

857
00:45:25,520 --> 00:45:27,560
Speaker 10: so that we are in control of our own distiny

858
00:45:27,640 --> 00:45:30,200
Speaker 10: is really important. Doesn't mean we only supply here, but

859
00:45:30,200 --> 00:45:32,160
Speaker 10: that we have the ability to ramp up very quickly.

860
00:45:32,400 --> 00:45:33,200
Speaker 2: I know the US.

861
00:45:33,040 --> 00:45:36,080
Speaker 10: Antibotics is, for example, a company that produces a maxicillin

862
00:45:36,400 --> 00:45:38,560
Speaker 10: I've meant, and there's not too many companies that do that,

863
00:45:38,600 --> 00:45:41,160
Speaker 10: and it's a basic drug, not a huge profit margin.

864
00:45:41,239 --> 00:45:46,440
Speaker 10: What happens is China supplements their industry with government supplementations

865
00:45:46,480 --> 00:45:48,400
Speaker 10: so they can undersell the rest of the market and

866
00:45:48,400 --> 00:45:51,080
Speaker 10: put everybody else out of business. Then they control the market.

867
00:45:51,320 --> 00:45:54,319
Speaker 10: They also control the basic elements for these drugs, and

868
00:45:54,360 --> 00:45:56,520
Speaker 10: that causes us a problem too. So basically, we need

869
00:45:56,560 --> 00:45:59,440
Speaker 10: to make sure that we are prepared so that when

870
00:45:59,480 --> 00:46:01,160
Speaker 10: the day comes, first of all, that we're able to

871
00:46:01,200 --> 00:46:04,560
Speaker 10: transition to a heartier production scale, but also we have

872
00:46:04,719 --> 00:46:08,160
Speaker 10: the basic elements to produce the medications to begin with.

873
00:46:08,719 --> 00:46:14,239
Speaker 5: Yeah, that strategic active pharmaceutical ingredients reserve or safe here.

874
00:46:14,320 --> 00:46:16,040
Speaker 7: I guess, as everybody calls it, that.

875
00:46:16,160 --> 00:46:18,759
Speaker 5: Was created under President Trump. But as John cited the

876
00:46:18,760 --> 00:46:21,160
Speaker 5: Biden administration to do anything about it, did they just

877
00:46:21,200 --> 00:46:23,160
Speaker 5: have a blind spot when it came.

878
00:46:23,000 --> 00:46:24,799
Speaker 6: To putting America first?

879
00:46:24,840 --> 00:46:26,440
Speaker 5: I mean that would have been really dangerous if there

880
00:46:26,480 --> 00:46:28,239
Speaker 5: had been another pandemic, because then they would have had

881
00:46:28,280 --> 00:46:29,000
Speaker 5: egg on their face.

882
00:46:29,000 --> 00:46:31,799
Speaker 10: Why didn't they, you know the question why they did

883
00:46:31,800 --> 00:46:33,720
Speaker 10: a lot of things, especially when it came to healthcare.

884
00:46:34,080 --> 00:46:36,240
Speaker 10: These guys didn't prep for anything. They didn't do anything

885
00:46:36,239 --> 00:46:39,760
Speaker 10: to save any money. But Sara's was probably the worst

886
00:46:40,200 --> 00:46:42,840
Speaker 10: Health in Human Services secretary of all time. He lost

887
00:46:42,960 --> 00:46:45,160
Speaker 10: for he was a lawyer, first of all, a lawyer

888
00:46:45,160 --> 00:46:50,000
Speaker 10: in charge of healthcare who lost four Supreme Court issues

889
00:46:50,400 --> 00:46:52,279
Speaker 10: to Texas when they sued him over and over again

890
00:46:52,320 --> 00:46:55,920
Speaker 10: because he was representing basically big insurance instead of healthcare.

891
00:46:56,440 --> 00:46:58,719
Speaker 10: This guy was totally sold up to specially interest. Like

892
00:46:58,760 --> 00:47:01,399
Speaker 10: a lot of the Biden administration, they didn't care about

893
00:47:01,400 --> 00:47:04,560
Speaker 10: controlling costs. They're totally bought into the Affordable Care Act

894
00:47:05,000 --> 00:47:10,120
Speaker 10: aka the Obamacare, which has not been anything to recognize

895
00:47:10,120 --> 00:47:11,799
Speaker 10: to affordable. Matter of fact, we had an increase of

896
00:47:11,800 --> 00:47:15,080
Speaker 10: our premiums of about thirty percent since that time, with

897
00:47:15,239 --> 00:47:18,680
Speaker 10: the reduction of reimbursements to physicians by about the same

898
00:47:18,760 --> 00:47:22,120
Speaker 10: when it just for income for inflation, which has forced

899
00:47:22,200 --> 00:47:25,560
Speaker 10: us into a hospital system that's way more expensive for everybody.

900
00:47:26,160 --> 00:47:30,239
Speaker 10: Is a single basic biggest cost to Americans out of

901
00:47:30,280 --> 00:47:32,000
Speaker 10: your pocketbook, out of your taxes.

902
00:47:32,320 --> 00:47:32,920
Speaker 2: It's about a.

903
00:47:32,840 --> 00:47:34,760
Speaker 10: Five trillion dollar industry here in America.

904
00:47:34,840 --> 00:47:35,680
Speaker 2: Over five trillion.

905
00:47:35,719 --> 00:47:37,200
Speaker 3: Now think about that.

906
00:47:37,120 --> 00:47:39,720
Speaker 10: That would be the size of the third large TDP

907
00:47:39,920 --> 00:47:42,279
Speaker 10: in the world, just what we spent on healthcare per year.

908
00:47:42,560 --> 00:47:45,400
Speaker 10: He didn't do anything to address that, absolutely a blind

909
00:47:45,400 --> 00:47:47,719
Speaker 10: spot in their administration. Just like so many things else,

910
00:47:47,920 --> 00:47:50,600
Speaker 10: they were not prepared. They didn't do anything to make

911
00:47:50,680 --> 00:47:52,720
Speaker 10: us independently strategically secure.

912
00:47:53,480 --> 00:47:55,080
Speaker 9: And by the way, don't forget their well reserves.

913
00:47:55,320 --> 00:47:58,440
Speaker 2: We don't have our own low reserves. Just kind of said, think.

914
00:47:58,440 --> 00:48:00,359
Speaker 9: We go to war right now, we are not ready.

915
00:48:00,400 --> 00:48:02,960
Speaker 10: And that's all on Biden's head, trying to buy votes

916
00:48:03,239 --> 00:48:04,840
Speaker 10: by warping the market.

917
00:48:05,280 --> 00:48:06,319
Speaker 2: Yeah, sir.

918
00:48:06,480 --> 00:48:09,120
Speaker 1: Another issue that is parallel to this, We not only

919
00:48:09,120 --> 00:48:11,319
Speaker 1: have trouble getting medicines to our men and women in

920
00:48:11,320 --> 00:48:13,840
Speaker 1: the front so lines because of the dependency on China.

921
00:48:14,239 --> 00:48:17,880
Speaker 1: But our system for developing our weapons and our supplies

922
00:48:17,880 --> 00:48:20,640
Speaker 1: for our troops is so antegrated and creaky, it's broken.

923
00:48:20,960 --> 00:48:23,759
Speaker 1: You've been taking an extraordinary lead on this. Everyone I

924
00:48:23,800 --> 00:48:26,680
Speaker 1: talked to is praising the work you're doing. Tell us

925
00:48:26,719 --> 00:48:30,600
Speaker 1: where that process stands, and what sort of procurement system

926
00:48:30,600 --> 00:48:32,000
Speaker 1: we might be able to look forward to in the

927
00:48:32,000 --> 00:48:33,080
Speaker 1: next few years.

928
00:48:34,520 --> 00:48:35,960
Speaker 9: You know, I just met with the six D of

929
00:48:35,960 --> 00:48:36,760
Speaker 9: the Air Force today.

930
00:48:37,120 --> 00:48:40,440
Speaker 10: He's a bipartson meeting, just talking about procurement, talk about

931
00:48:40,440 --> 00:48:43,359
Speaker 10: which programs are doing well, which ones are not. When

932
00:48:43,400 --> 00:48:46,719
Speaker 10: you talk about procurement, it always if it starts well,

933
00:48:46,719 --> 00:48:49,080
Speaker 10: it ends well. If it starts badly, it ends badly.

934
00:48:49,719 --> 00:48:50,799
Speaker 2: We are done with.

935
00:48:50,880 --> 00:48:55,200
Speaker 10: The broken process where we're we're fifty percent, one hundred

936
00:48:55,239 --> 00:48:58,000
Speaker 10: fifty percent over budget six months or a year, a

937
00:48:58,040 --> 00:48:58,279
Speaker 10: year and.

938
00:48:58,280 --> 00:48:59,960
Speaker 2: A half behind on timeliness.

939
00:49:00,120 --> 00:49:02,120
Speaker 10: We have really been doing it poor job on this,

940
00:49:02,640 --> 00:49:03,719
Speaker 10: and the time.

941
00:49:03,480 --> 00:49:05,680
Speaker 9: For those kind of wasteful days is way over.

942
00:49:06,440 --> 00:49:09,000
Speaker 3: Luckily we've got our arms around this.

943
00:49:10,200 --> 00:49:15,120
Speaker 10: Chairman Rogers has been super aggressive in this regard, and

944
00:49:15,200 --> 00:49:16,560
Speaker 10: I think it's just time to do.

945
00:49:16,480 --> 00:49:19,920
Speaker 5: Things right, doctor, Marine Corps veteran and Congressman Rich mcormick, Sir,

946
00:49:19,960 --> 00:49:22,040
Speaker 5: thank you so much for being with us tonight. We

947
00:49:22,080 --> 00:49:23,920
Speaker 5: hope you enjoyed that I have to met John. When

948
00:49:23,920 --> 00:49:27,040
Speaker 5: we first started these conversations, I went from very very

949
00:49:27,080 --> 00:49:30,600
Speaker 5: scared to now feeling pretty darn good about the options

950
00:49:30,600 --> 00:49:31,880
Speaker 5: and the solutions that our country has.

951
00:49:31,920 --> 00:49:33,759
Speaker 1: We were hanging this far from the abyss of a

952
00:49:33,800 --> 00:49:35,800
Speaker 1: major crisis. Now we got a solution place. We just

953
00:49:35,800 --> 00:49:37,520
Speaker 1: got to keep it running fast until it gets there.

954
00:49:37,560 --> 00:49:40,440
Speaker 1: But I feel better too, as all the future.

955
00:49:40,360 --> 00:49:41,360
Speaker 5: Back from the cliff.

956
00:49:41,400 --> 00:49:41,960
Speaker 6: Thank goodness.

957
00:49:42,040 --> 00:49:44,160
Speaker 5: Yeah, and thank you to all of our guests who

958
00:49:44,200 --> 00:49:47,040
Speaker 5: have been here for three different specials giving their opinions

959
00:49:47,080 --> 00:49:49,560
Speaker 5: on this and offering wisdom on all of these critical issues.

960
00:49:49,600 --> 00:49:52,400
Speaker 5: We hope you all have a fantastic evening, a wonderful weekend,

961
00:49:52,640 --> 00:49:54,759
Speaker 5: and we'll be back here on Monday at six pm

962
00:49:54,800 --> 00:49:55,120
Speaker 5: Eastern